<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group>
<journal-title>Frontiers in Pediatrics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pediatr.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fped.2026.1659176</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Mini Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The era of &#x201C;Infectious Diseases&#x002B;&#x201D; has arrived: multi-disciplinary integration in pediatric infectious disease prevention and control</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Kong</surname><given-names>Dechuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/3044013/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Hao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Huanyu</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Jian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Communicable Diseases Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Shanghai Municipal Center for Disease Control and Prevention</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Jian Chen <email xlink:href="mailto:chenjian@scdc.sh.cn">chenjian@scdc.sh.cn</email> Huanyu Wu <email xlink:href="mailto:wuhuanyu@scdc.sh.cn">wuhuanyu@scdc.sh.cn</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-03-10"><day>10</day><month>03</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>14</volume><elocation-id>1659176</elocation-id>
<history>
<date date-type="received"><day>03</day><month>07</month><year>2025</year></date>
<date date-type="rev-recd"><day>28</day><month>11</month><year>2025</year></date>
<date date-type="accepted"><day>02</day><month>02</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Kong, Pan, Wu and Chen.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Kong, Pan, Wu and Chen</copyright-holder><license><ali:license_ref start_date="2026-03-10">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract>
<p>The frequency of emerging infectious diseases have exposed the limitations of traditional response models, which are increasingly inadequate for contemporary prevention and control needs. History has repeatedly demonstrated the necessity of multi-disciplinary collaboration. Advances in multiple fields and technological revolutions now provide new tools to address these challenges. &#x201C;Infectious Diseases&#x002B;&#x201D; (ID&#x002B;) is an interdisciplinary integration concept that centers on infectious disease prevention and control. We introduce ID&#x002B; as an innovative paradigm for next-generation epidemic control, featuring: (a) three theoretical breakthroughs vs. conventional methods, (b) cross-disciplinary applications from AI-driven prediction to vaccine equity governance, and (c) validated pediatric use cases. Future scaling pathways are also discussed.</p>
</abstract>
<kwd-group>
<kwd>artificial intelligence</kwd>
<kwd>global public health</kwd>
<kwd>infectious diseases</kwd>
<kwd>social science</kwd>
<kwd>vaccine</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by &#x201C;Medical Innovation Research&#x201D; Project(25Y32800200) under the Shanghai Municipal Commission of Science and Technology&#x0027;s 2025 Key Technology Research and Development Program; Academic Research Leader (GWVI-11.2-XD04&#xFF09;of Three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System (2023-2025); Key Discipline-Infectious Diseases (No. GWVI-11.1-01) of Three-year Action Program of Shanghai Municipality for Strength-ening the Construction of Public Health System (2023&#x2013;2025).</funding-statement></funding-group><counts>
<fig-count count="2"/>
<table-count count="1"/><equation-count count="0"/><ref-count count="147"/><page-count count="9"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pediatric Infectious Diseases</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Over the past three decades, emerging infectious diseases such as SARS, H5N1 avian influenza, MERS, Ebola, and COVID-19 have continued to emerge globally, with major outbreaks occurring every 4&#x2013;5 years on average (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Additionally, climate change is reshaping the geographic distribution of these diseases (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). As an example, the habitable range of Aedes mosquitoes, vectors of dengue fever, has expanded in European (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>). Furthermore, the thawing of permafrost may release unknown pathogens (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>This increased frequency of emerging infectious diseases have exposed the limitations of traditional response models, which are increasingly inadequate for contemporary prevention and control needs. Critical shortcoming with conventional surveillance diagnosis, treatment and vaccine/drug development were revealed during COVID-19. For example, traditional surveillance systems lacked sufficient sensitivity and intelligence, failing to meet the demands of early detection and large-scale emergency response (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Similarly, vaccine development cycles could not keep pace with the rapid transmission and mutation of viruses (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>History has repeatedly demonstrated the necessity of multi-disciplinary collaboration. Rapid advances across multiple disciplines, alongside revolutionary technological breakthroughs, are now empowering us with novel means to overcome these challenges. Big data analytics, artificial intelligence, nanotechnology, mRNA vaccine technology, CRISPR gene editing, have opened new frontiers in infectious disease control. The multi-point trigger and intelligent early warning surveillance system recently launched by China&#x0027;s National Disease Control and Prevention Administration exemplifies the practical application of the systems like &#x201C;Infectious Diseases&#x002B;&#x201D; (ID&#x002B;) concept (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Moreover, the ID&#x002B; approach serves as an essential methodology for implementing the One Health framework at the operational level (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>). The prevention and control of pediatric infectious diseases requires the integrated application of ID&#x002B;, with its core rationale lying in the unique characteristics of the pediatric population and the complexity of infectious disease management. Undoubtedly, ID&#x002B; represents the most critical characteristic of infectious disease prevention and control in the new era.</p>
</sec>
<sec id="s2"><label>2</label><title>The ID&#x002B; concept</title>
<p>ID&#x002B; is an innovative interdisciplinary integration concept that centers on infectious disease prevention and control. It aims to establish a strategic framework for a comprehensive &#x201C;prediction&#x2009;&#x003E;&#x2009;early warning&#x2009;&#x003E;&#x2009;prevention&#x2009;&#x003E;&#x2009;treatment&#x201D; system through interdisciplinary collaboration, technological empowerment, and global governance enhancement. One Health and ID&#x002B; are both integrative concepts, but they differ significantly in their scope, core philosophy, and primary focus. ID&#x002B; can be a powerful application and a component of the broader One Health philosophy within the specific context of infectious diseases. One Health provides the overarching ethical and theoretical framework for ID&#x2009;&#x002B;&#x2009;. Our paper marks the global introduction of ID&#x002B; concept, whose core philosophy lies in breaking down disciplinary barriers and transforming infectious disease prevention and control from a traditional public health emergency response into a complex integrated systems approach, addressing the addressing the multifaceted challenges of emerging infectious diseases in the modern era.</p>
<sec id="s2a"><label>2.1</label><title>Differences between ID&#x002B; and traditional infectious disease theories</title>
<p>Compared with traditional infectious disease theories, ID&#x002B; differs in academic science, response speed, decision making, intervention tool, data flow, governance model, precision level, and cost efficiency. For details, see <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>.</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Comparison between traditional and next-Gen infectious diseases paradigms.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Dimensions</th>
<th valign="top" align="center">Traditional infectious diseases</th>
<th valign="top" align="center">ID&#x002B; Approach</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><sans-serif>Academic Science</sans-serif></td>
<td valign="top" align="left"><sans-serif>Medicine/Epidemiology dominated</sans-serif></td>
<td valign="top" align="left"><sans-serif>Medicine&#x2009;&#x002B;&#x2009;(AI/Climatology/ Social Science/ others) integration</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Response Speed</sans-serif></td>
<td valign="top" align="left"><sans-serif>Reactive (post-outbreak)</sans-serif></td>
<td valign="top" align="left"><sans-serif>Proactive (pre-outbreak interception)</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Decision Making</sans-serif></td>
<td valign="top" align="left"><sans-serif>Limited case data</sans-serif></td>
<td valign="top" align="left"><sans-serif>Real-time multisource data fusion (genomic, climate, behavioral, et al)</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Intervention Tool</sans-serif></td>
<td valign="top" align="left"><sans-serif>Vaccines&#x2009;&#x002B;&#x2009;Quarantine&#x2009;&#x002B;&#x2009;Treatment</sans-serif></td>
<td valign="top" align="left"><sans-serif>Vaccines&#x2009;&#x002B;&#x2009;AI prediction&#x2009;&#x002B;&#x2009;Environmental modification&#x2009;&#x002B;&#x2009;Behavioral nudges</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Data Flow</sans-serif></td>
<td valign="top" align="left"><sans-serif>Weekly/Monthly reports</sans-serif></td>
<td valign="top" align="left"><sans-serif>Real-time streaming analytics</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Governance Model</sans-serif></td>
<td valign="top" align="left"><sans-serif>Government-led vertical command</sans-serif></td>
<td valign="top" align="left"><sans-serif>Distributed autonomous networks</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Precision Level</sans-serif></td>
<td valign="top" align="left"><sans-serif>Population-level measures</sans-serif></td>
<td valign="top" align="left"><sans-serif>Individualized risk profiling</sans-serif></td>
</tr>
<tr>
<td valign="top" align="left"><sans-serif>Cost Efficiency</sans-serif></td>
<td valign="top" align="left"><sans-serif>High marginal costs</sans-serif></td>
<td valign="top" align="left"><sans-serif>Declining marginal costs</sans-serif></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2b"><label>2.2</label><title>The three core dimensions and theoretical innovations of ID&#x002B;</title>
<p>The three core dimensions of ID&#x002B; are reflected in advancing novel technologies (intelligent prediction, precision interventions, novel therapeutics, et al.), interdisciplinary collaborations (climate medicine and social behavioral science, et al.), and systematic theories (One Health, global coordination, community engagement, et al.). The innovation of ID&#x002B; lies in the application of complexity science (<xref ref-type="fig" rid="F1">Figure 1</xref>). Traditional prevention/control theories of infectious diseases collide with these new elements, selectively assimilating their merits to form ID&#x002B;&#x2014;an ecosystem of interconnected, co-adaptive, and perpetually evolving components.</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>The schematic diagram of three core dimensions and theoretical innovations of ID&#x002B;. The circles in different colors represent the core of infectious diseases in ID&#x002B; and the three introduced elements (systematic theories, advancing novel technologies, and interdisciplinary collaborations). The solid lines indicate the extensive connections and dynamically changing nature between the infectious disease core and each element.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-14-1659176-g001.tif"><alt-text content-type="machine-generated">Venn diagram with a central red circle labeled Infectious Diseases, connected to three other circles: blue for Systematic Theories (One Health, global coordination, community engagement), yellow for Advancing Novel Technologies (intelligent prediction, precision interventions, novel therapeutics), and green for Interdisciplinary Collaborations (climate medicine and social behavioral science).</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s3"><label>3</label><title>Core domains of ID&#x002B;</title>
<p>The core domains of ID&#x002B; primarily encompass Artificial Intelligence (AI), Therapeutic Interventions, Global Public Health, and Social Sciences (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>The core components of ID&#x002B;, Its advancements in pediatric infectious diseases, and future trends.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-14-1659176-g002.tif"><alt-text content-type="machine-generated">Flowchart showing three columns. Left column, titled Core Domains of ID+, lists Artificial Intelligence, Vaccine Technologies, Global Public Health, and Social Sciences. Middle column, New Trends in Pediatric Infectious Disease, lists immunization, prevention awareness, safer spaces, smart detection tools, and collective defense networks. Right column, The Future of ID+, lists Precision Public Health, Climate Adaptation, and Biotech Innovation.</alt-text>
</graphic>
</fig>
<sec id="s3a"><label>3.1</label><title>Integration of infectious diseases and artificial intelligence (AI)</title>
<p>The ID&#x002B; AI approach demonstrates transformative potential across multiple domains: AI-powered epidemic prediction models (e.g., influenza trend analysis via big data) (<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>), rapid pathogen genome sequencing and variant tracking (exemplified by AlphaFold&#x0027;s viral protein structure prediction) (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>), and intelligent diagnostics (such as AI-based imaging recognition for tuberculosis/malaria) (<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>). Notable implementations include Google DeepMind&#x0027;s breakthrough in forecasting SARS-CoV-2 spike protein structures (<xref ref-type="bibr" rid="B43">43</xref>&#x2013;<xref ref-type="bibr" rid="B46">46</xref>) and BlueDot&#x0027;s AI-driven early warning system that detected COVID-19 spread 9 days before WHO alerts (<xref ref-type="bibr" rid="B47">47</xref>&#x2013;<xref ref-type="bibr" rid="B49">49</xref>). This synergy enables high-speed real-time analytics (Nanopore Sequencing, Whole Genome Sequencing, Pattern Recognition and Classification Framework using XGBoost and Decision Trees) (<xref ref-type="bibr" rid="B50">50</xref>&#x2013;<xref ref-type="bibr" rid="B52">52</xref>) and precision public health (AI-powered screening, Genomic and environmental integration, Personalized Interventions, Pandemic and Outbreak Management) (<xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B60">60</xref>), fundamentally accelerating the outbreak response paradigm from months to hours.</p>
</sec>
<sec id="s3b"><label>3.2</label><title>Integration of infectious diseases and vaccines/therapeutic interventions</title>
<p>The ID&#x002B; Vaccines/Therapeutic Interventions paradigm is revolutionizing disease prevention through cutting-edge platforms: mRNA vaccines (exemplified by Moderna/BioNTech&#x0027;s COVID-19 vaccines achieving highest efficacy) (<xref ref-type="bibr" rid="B61">61</xref>), nanoparticle vaccines (e.g., malaria/HIV candidates inducing robust T-cell responses) (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>), and universal vaccines (broad-spectrum protection against influenza/coronaviruses) (<xref ref-type="bibr" rid="B63">63</xref>). This field is transitioning from traditional passive immunization to proactive preventive/therapeutic strategies, as evidenced by cancer vaccines (<xref ref-type="bibr" rid="B64">64</xref>). Current innovations enable faster development cycles (COVID-19 vaccines in 9 months vs. historical 10 years) (<xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B68">68</xref>) and cross-variant protection (nanoparticle flu vaccines covering 20&#x002B; strains) (<xref ref-type="bibr" rid="B69">69</xref>&#x2013;<xref ref-type="bibr" rid="B71">71</xref>). The future will see vaccines assuming a larger role, showcasing an evolution from prevention to therapy and from infectious to chronic diseases.</p>
</sec>
<sec id="s3c"><label>3.3</label><title>Integration of infectious diseases and global public health</title>
<p>The ID&#x002B; Global Public Health framework represents a transformative shift in pandemic preparedness through two key innovations: One Health integration (bridging human-animal-environment health monitoring, as seen in cross-species H5N1 surveillance) (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>) and global pathogen surveillance networks (exemplified by WHO&#x0027;s Pandemic Accord establishing data-sharing protocols) (<xref ref-type="bibr" rid="B74">74</xref>&#x2013;<xref ref-type="bibr" rid="B76">76</xref>). However, this approach faces critical challenges, particularly vaccine equity gaps&#x2014;during COVID-19, &#x201C;vaccine nationalism&#x201D; resulted in 63&#x0025; of the population of high-income countries were fully vaccinated, compared to just 1.4&#x0025; of low-income countries (<xref ref-type="bibr" rid="B77">77</xref>). Advanced technology platforms (e.g., mRNA vaccines) were predominantly concentrated in wealthier regions, while the introduction and evaluation of other platforms lagged (<xref ref-type="bibr" rid="B78">78</xref>). Enhancing the thermostability of vaccines is a critical step toward promoting global vaccine equity. It directly determines whether vaccines can safely and efficiently reach remote and resource-limited areas with unstable electricity and inadequate cold chain infrastructure (<xref ref-type="bibr" rid="B79">79</xref>). Modern solutions include GISAID&#x0027;s genomic data platform (accelerating variant analysis) (<xref ref-type="bibr" rid="B80">80</xref>&#x2013;<xref ref-type="bibr" rid="B82">82</xref>) and COVAX&#x0027;s allocation mechanism, though systemic reforms remain imperative to achieve the target of 100-day pandemic vaccine deployment for all nations (<xref ref-type="bibr" rid="B83">83</xref>&#x2013;<xref ref-type="bibr" rid="B85">85</xref>).</p>
</sec>
<sec id="s3d"><label>3.4</label><title>Integration of infectious diseases and social sciences</title>
<p>Non-Pharmaceutical Interventions&#xFF08;NPIs&#xFF09;are actions, outside of vaccines and antiviral drugs, that individuals and communities can take to help slow the spread of respiratory infectious diseases like COVID-19, influenza, and others. They are often the first line of defense, especially when a pathogen is new and no specific pharmaceutical treatments are available. NPIs are typically categorized by the level at which they are implemented: personal, community, and environmental, such as face masks, isolation, quarantine, social distancing. The ID&#x002B; Social Sciences approach critically examines behavioral dimensions of outbreaks through two pivotal research streams: misinformation dynamics (where social media algorithms amplified vaccine hesitancy during COVID-19) (<xref ref-type="bibr" rid="B86">86</xref>&#x2013;<xref ref-type="bibr" rid="B88">88</xref>) and policy compliance psychology (lockdown adherence correlates with trust in institutions) (<xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B92">92</xref>) This interdisciplinary field employs computational social science methods which revealed anti-vaccine narratives spread faster than factual content (<xref ref-type="bibr" rid="B93">93</xref>&#x2013;<xref ref-type="bibr" rid="B95">95</xref>), while behavioral experiments demonstrate that &#x201C;nudge&#x201D;-based interventions (e.g., vaccination lotteries) can increase compliance (<xref ref-type="bibr" rid="B96">96</xref>&#x2013;<xref ref-type="bibr" rid="B98">98</xref>) Emerging tools include AI-powered infodemic monitoring (WHO&#x0027;s EPI-WIN system) and cultural risk mapping predicting regional resistance to containment measures (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). Using social media data and machine learning techniques, the preeminent roles parks and greenspaces play during the pandemic and guides a new direction in future urban planning requirements (<xref ref-type="bibr" rid="B101">101</xref>).</p>
</sec>
</sec>
<sec id="s4"><label>4</label><title>New trends in pediatric infectious disease prevention and control in the Era of ID&#x002B;</title>
<p>New trends in pediatric infectious disease prevention and control under the ID&#x002B; framework encompass: (1) ID&#x002B; vaccination strategies, (2) ID&#x002B; health education, (3) ID&#x002B; environmental control, (4) ID&#x002B; digital surveillance technologies, and (5) ID&#x002B; family-community integrated interventions (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<sec id="s4a"><label>4.1</label><title>ID&#x002B; vaccination: building comprehensive immunization protection for children</title>
<p>The ID&#x002B; approach can revolutionize childhood vaccination by integrating advanced technologies and systematic strategies. It advocates for lifelong immunization planning, ensuring vaccine coverage from infancy through adolescence. By developing multivalent combination vaccines (<xref ref-type="bibr" rid="B102">102</xref>&#x2013;<xref ref-type="bibr" rid="B105">105</xref>), the number of required injections can be reduced, improving compliance and minimizing discomfort for young children. Big data analytics further enhance vaccination programs by tracking immunization records in real time, identifying missed doses, and enabling targeted catch-up campaigns (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B107">107</xref>). Mobile health platforms can send automated reminders to parents, while AI-powered systems predict regional outbreaks, allowing preemptive vaccination drives in high-risk areas (<xref ref-type="bibr" rid="B108">108</xref>, <xref ref-type="bibr" rid="B109">109</xref>). This data-driven, precision-based model ensures that no child is left unprotected due to logistical or informational gaps.</p>
</sec>
<sec id="s4b"><label>4.2</label><title>ID&#x002B; health education: cultivating prevention awareness from early childhood</title>
<p>Effective health education is crucial in empowering children to understand and prevent infectious diseases. The ID&#x002B; framework promotes age-appropriate educational materials, using animated videos, interactive storybooks, and augmented reality (AR) tools to teach hygiene practices (<xref ref-type="bibr" rid="B110">110</xref>&#x2013;<xref ref-type="bibr" rid="B114">114</xref>). Schools and kindergartens integrate handwashing drills, respiratory etiquette, and disease prevention modules into daily routines. Gamification techniques&#x2014;such as reward-based hygiene apps&#x2014;make learning engaging, encouraging children to adopt healthy habits voluntarily (<xref ref-type="bibr" rid="B115">115</xref>). Teacher training programs ensure educators can deliver accurate, engaging lessons on infectious disease risks. By embedding health literacy early, this approach fosters generations that are likely to me more understanding of the necessity for future public health interventions.</p>
</sec>
<sec id="s4c"><label>4.3</label><title>ID&#x002B; environmental control: creating safer spaces for children</title>
<p>Children are particularly vulnerable to pathogens in crowded environments like schools and daycare centers. ID&#x002B; advocates for enhanced sanitation protocols, including automated disinfection systems, antimicrobial surfaces, and improved ventilation with HEPA filters. Real-time air quality monitors can detect pathogens, triggering instant sterilization in high-risk zones (<xref ref-type="bibr" rid="B116">116</xref>&#x2013;<xref ref-type="bibr" rid="B118">118</xref>). Playgrounds and classrooms are redesigned to minimize high-touch surfaces, while UV-C light robots disinfect spaces overnight. Additionally, &#x201C;green hygiene&#x201D; solutions&#x2014;such as plant-based disinfectants&#x2014;reduce chemical exposure for young children (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>). These innovations transform child-centric spaces into low-risk zones, significantly cutting transmission rates of flu, RSV, and other common infections.</p>
</sec>
<sec id="s4d"><label>4.4</label><title>ID&#x002B; digital technology: smart tools for early detection and monitoring</title>
<p>Digital advancements underpin the ID&#x002B; strategy for pediatric care. Wearable devices (e.g., smart thermometers or biosensor patches) track children&#x0027;s vital signs, flagging early symptoms like fever or irregular heart rates (<xref ref-type="bibr" rid="B121">121</xref>&#x2013;<xref ref-type="bibr" rid="B123">123</xref>) AI-driven outbreak prediction systems analyze school absenteeism data and online search trends to detect anomalies (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). Electronic health records (EHRs) centralize medical histories, allowing seamless coordination between parents, schools, and doctors (<xref ref-type="bibr" rid="B126">126</xref>). Telemedicine platforms enable remote consultations, reducing unnecessary hospital visits. Blockchain technology secures data privacy while ensuring transparent outbreak tracking (<xref ref-type="bibr" rid="B127">127</xref>). Together, these tools create a real-time health shield for children, enabling swift responses to potential threats.</p>
</sec>
<sec id="s4e"><label>4.5</label><title>ID&#x002B; family and community: strengthening collective defense networks</title>
<p>The final pillar of ID&#x002B; focuses on community-driven protection. Parents receive training via workshops and mobile apps to recognize symptoms, administer basic care, and implement home quarantine protocols. Neighborhood &#x201C;buddy systems&#x201D; connect families for resource sharing (e.g., delivering medicines or groceries during outbreaks) (<xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B129">129</xref>). Schools and clinics collaborate through joint drills (e.g., simulating measles containment), while social workers identify at-risk households. Local governments incentivize participation through &#x201C;healthy community certifications&#x201D; for districts achieving high vaccination rates (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B131">131</xref>). By weaving families, schools, and medical institutions into a unified prevention web, the model ensures no child falls through the cracks&#x2014;turning communities into active defenders against infectious diseases.</p>
</sec>
<sec id="s4f"><label>4.6</label><title>Implementation of the ID&#x002B; framework for respiratory syncytial virus (RSV) outbreak management in daycare centers</title>
<p>Respiratory Syncytial Virus (RSV) represents a significant and recurrent public health challenge, particularly in daycare settings where close-contact environments facilitate its rapid transmission (<xref ref-type="bibr" rid="B132">132</xref>). RSV outbreaks not only cause widespread illness among young children, but also lead to substantial operational disruptions for childcare centers and force parents to miss work. The ID&#x002B; Framework offers a structured, multi-phase approach for outbreak management that is particularly suited to the dynamic and high-stakes environment of a daycare center. This framework guides responders from initial identification through to post-outbreak analysis, ensuring a comprehensive and systematic response.</p>
<sec id="s4f1"><label>4.6.1</label><title>Investigate and detect</title>
<p>The system employs an intelligent, multi-source surveillance mechanism that integrates environmental risk prediction models (<xref ref-type="bibr" rid="B133">133</xref>), wastewater-based monitoring (<xref ref-type="bibr" rid="B134">134</xref>), the Smart Wearable-Based System for Monitoring Student Symptoms (<xref ref-type="bibr" rid="B135">135</xref>), and Saliva-Based rapid molecular testing (<xref ref-type="bibr" rid="B136">136</xref>).</p>
</sec>
<sec id="s4f2"><label>4.6.2</label><title>Decisive interventions</title>
<p>Infection control and resource allocation strategies incorporate advanced technologies such as robotic disinfection (<xref ref-type="bibr" rid="B137">137</xref>), proactive immunoprophylaxis (<xref ref-type="bibr" rid="B138">138</xref>), assessment Tool for Respiratory Syncytial Virus Infection in Infants (<xref ref-type="bibr" rid="B139">139</xref>).</p>
</sec>
<sec id="s4f3"><label>4.6.3</label><title>Disseminate &#x0026; integrate</title>
<p>The framework strengthens coordinated response and public communication through community-based home monitoring (<xref ref-type="bibr" rid="B140">140</xref>), targeted health education (<xref ref-type="bibr" rid="B141">141</xref>).</p>
<p>In summary, managing an RSV outbreak in a daycare setting is a complex endeavor. By adopting the proactive, phased, and systematic ID&#x002B; Framework, daycare administrators and public health responders can shift from a reactive posture to one of controlled management. This approach not only enhances the effectiveness of outbreak containment but also builds the center&#x0027;s resilience against future infectious disease threats.</p>
</sec>
</sec>
</sec>
<sec id="s5"><label>5</label><title>The future of ID&#x002B;: precision, climate adaptation, and biotech innovation</title>
<p>The ID&#x002B; paradigm is evolving toward precision public health, where real-time genomic sequencing integrated with digital contact tracing (like China&#x0027;s Health Code system) enables instant outbreak containment (<xref ref-type="bibr" rid="B142">142</xref>). Meanwhile, climate change is reshaping disease patterns, as warming temperatures expand mosquito habitats northward, bringing malaria, dengue and chikungunya to new regions while potentially awakening ancient pathogens from thawing permafrost (<xref ref-type="bibr" rid="B143">143</xref>). Synthetic biology presents both unprecedented risks&#x2014;including engineered biothreats like synthetic smallpox&#x2014;and revolutionary solutions (<xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B145">145</xref>), from CRISPR-modified mosquitoes that block malaria transmission to designer probiotic &#x201C;shield microbes&#x201D; that outcompete pathogens (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B147">147</xref>). This trifecta of digital epidemiology, climate resilience, and genetic engineering will define the next generation of pandemic preparedness, demanding equally sophisticated global governance frameworks to safely harness these transformative technologies (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<p>The future development of ID&#x002B; faces severe ethical challenges. The core issue lies in the fact that highly integrated personal data may lead to unprecedented risks of privacy breaches and surveillance; embedded algorithmic biases could solidify social discrimination and systematically exclude certain groups. We must proactively establish ethical and legal frameworks to ensure that technological advancement doesn&#x0027;t come at the cost of compromising human privacy, fairness, and security.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="author-contributions"><title>Author contributions</title>
<p>DK: Conceptualization, Data curation, Investigation, Methodology, Software, Validation, Visualization, Writing &#x2013; original draft. HP: Conceptualization, Resources, Supervision, Writing &#x2013; review &#x0026; editing. HW: Conceptualization, Resources, Supervision, Writing &#x2013; review &#x0026; editing. JC: Conceptualization, Resources, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s10" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>KE</given-names></name> <name><surname>Patel</surname> <given-names>NG</given-names></name> <name><surname>Levy</surname> <given-names>MA</given-names></name> <name><surname>Storeygard</surname> <given-names>A</given-names></name> <name><surname>Balk</surname> <given-names>D</given-names></name> <name><surname>Gittleman</surname> <given-names>JL</given-names></name><etal/></person-group> <article-title>Global trends in emerging infectious diseases</article-title>. <source>Nature</source>. (<year>2008</year>) <volume>451</volume>(<issue>7181</issue>):<fpage>990</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nature06536</pub-id><pub-id pub-id-type="pmid">18288193</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>W</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Yang</surname> <given-names>W</given-names></name> <name><surname>Xia</surname> <given-names>X</given-names></name> <name><surname>Yan</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2024</year>) <volume>9</volume>(<issue>1</issue>):<fpage>223</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-024-01917-x</pub-id><pub-id pub-id-type="pmid">39256346</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristori</surname> <given-names>MV</given-names></name> <name><surname>Guarrasi</surname> <given-names>V</given-names></name> <name><surname>Soda</surname> <given-names>P</given-names></name> <name><surname>Petrosillo</surname> <given-names>N</given-names></name> <name><surname>Gurrieri</surname> <given-names>F</given-names></name> <name><surname>Longo</surname> <given-names>UG</given-names></name><etal/></person-group> <article-title>Emerging microorganisms and infectious diseases: one health approach for health shared vision</article-title>. <source>Genes (Basel)</source>. (<year>2024</year>) <volume>15</volume>(<issue>7</issue>):<fpage>908</fpage>. <pub-id pub-id-type="doi">10.3390/genes15070908</pub-id><pub-id pub-id-type="pmid">39062687</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandato</surname> <given-names>C</given-names></name> <name><surname>Colucci</surname> <given-names>A</given-names></name> <name><surname>Vajro</surname> <given-names>P</given-names></name></person-group>. <article-title>Emerging, re-emerging and/or atypically behaving infectious diseases</article-title>. <source>Acta Paediatr Oslo Nor 1992</source>. (<year>2023</year>) <volume>112</volume>(<issue>6</issue>):<fpage>1145</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/apa.16744</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keesing</surname> <given-names>F</given-names></name> <name><surname>Ostfeld</surname> <given-names>RS</given-names></name></person-group>. <article-title>Emerging patterns in rodent-borne zoonotic diseases</article-title>. <source>Science</source>. (<year>2024</year>) <volume>385</volume>(<issue>6715</issue>):<fpage>1305</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1126/science.adq7993</pub-id><pub-id pub-id-type="pmid">39298587</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="other"><collab>Future surveillance for epidemic and pandemic diseases: a 2023 perspective</collab>. (<year>2023</year>). <comment>Available online at</comment>: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240080959">https://www.who.int/publications/i/item/9789240080959</ext-link> <comment>(Accessed May 31, 2025)</comment>.</mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couper</surname> <given-names>LI</given-names></name> <name><surname>MacDonald</surname> <given-names>AJ</given-names></name> <name><surname>Mordecai</surname> <given-names>EA</given-names></name></person-group>. <article-title>Impact of prior and projected climate change on US lyme disease incidence</article-title>. <source>Glob Change Biol</source>. (<year>2021</year>) <volume>27</volume>(<issue>4</issue>):<fpage>738</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/gcb.15435</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Yang</surname> <given-names>R</given-names></name> <name><surname>Ganbold</surname> <given-names>D</given-names></name> <name><surname>Tsogbadrakh</surname> <given-names>N</given-names></name> <name><surname>Dong</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Climate-driven marmot-plague dynamics in Mongolia and China</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>(<issue>1</issue>):<fpage>11906</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-023-38966-1</pub-id><pub-id pub-id-type="pmid">37488160</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>H</given-names></name> <name><surname>Lyon</surname> <given-names>CJ</given-names></name> <name><surname>Ying</surname> <given-names>B</given-names></name> <name><surname>Hu</surname> <given-names>T</given-names></name></person-group>. <article-title>Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge</article-title>. <source>Emerg Microbes Infect</source>. (<year>2024</year>) <volume>13</volume>(<issue>1</issue>):<fpage>2356143</fpage>. <pub-id pub-id-type="doi">10.1080/22221751.2024.2356143</pub-id><pub-id pub-id-type="pmid">38767202</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname> <given-names>N</given-names></name></person-group>. <article-title>Climate change and emerging infectious diseases: a precarious relationship</article-title>. <source>AACN Adv Crit Care</source>. (<year>2024</year>) <volume>35</volume>(<issue>4</issue>):<fpage>325</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.4037/aacnacc2024290</pub-id><pub-id pub-id-type="pmid">39642076</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezirtzoglou</surname> <given-names>C</given-names></name> <name><surname>Dekas</surname> <given-names>K</given-names></name> <name><surname>Charvalos</surname> <given-names>E</given-names></name></person-group>. <article-title>Climate changes, environment and infection: facts, scenarios and growing awareness from the public health community within Europe</article-title>. <source>Anaerobe</source>. (<year>2011</year>) <volume>17</volume>(<issue>6</issue>):<fpage>337</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.05.016</pub-id><pub-id pub-id-type="pmid">21664978</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeller</surname> <given-names>H</given-names></name> <name><surname>Marrama</surname> <given-names>L</given-names></name> <name><surname>Sudre</surname> <given-names>B</given-names></name> <name><surname>Van Bortel</surname> <given-names>W</given-names></name> <name><surname>Warns-Petit</surname> <given-names>E</given-names></name></person-group>. <article-title>Mosquito-borne disease surveillance by the European centre for disease prevention and control</article-title>. <source>Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis</source>. (<year>2013</year>) <volume>19</volume>(<issue>8</issue>):<fpage>693</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/1469-0691.12230</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname> <given-names>JC</given-names></name> <name><surname>Suk</surname> <given-names>JE</given-names></name></person-group>. <article-title>Vector-borne diseases and climate change: a European perspective</article-title>. <source>FEMS Microbiol Lett</source>. (<year>2018</year>) <volume>365</volume>(<issue>2</issue>):<fpage>fnx244</fpage>. <pub-id pub-id-type="doi">10.1093/femsle/fnx244</pub-id><pub-id pub-id-type="pmid">29149298</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernakovich</surname> <given-names>JG</given-names></name> <name><surname>Barbato</surname> <given-names>RA</given-names></name> <name><surname>Rich</surname> <given-names>VI</given-names></name> <name><surname>Sch&#x00E4;del</surname> <given-names>C</given-names></name> <name><surname>Hewitt</surname> <given-names>RE</given-names></name> <name><surname>Doherty</surname> <given-names>SJ</given-names></name><etal/></person-group> <article-title>Microbiome assembly in thawing permafrost and its feedbacks to climate</article-title>. <source>Glob Change Biol</source>. (<year>2022</year>) <volume>28</volume>(<issue>17</issue>):<fpage>5007</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/gcb.16231</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackelprang</surname> <given-names>R</given-names></name> <name><surname>Barbato</surname> <given-names>RA</given-names></name> <name><surname>Ramey</surname> <given-names>AM</given-names></name> <name><surname>Sch&#x00FC;tte</surname> <given-names>UME</given-names></name> <name><surname>Waldrop</surname> <given-names>MP</given-names></name></person-group>. <article-title>Cooling perspectives on the risk of pathogenic viruses from thawing permafrost</article-title>. <source>mSystems</source>. (<year>2025</year>) <volume>10</volume>(<issue>2</issue>):<fpage>e0004224</fpage>. <pub-id pub-id-type="doi">10.1128/msystems.00042-24</pub-id><pub-id pub-id-type="pmid">39772968</pub-id></mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>R</given-names></name> <name><surname>Bottos</surname> <given-names>EM</given-names></name> <name><surname>Danna</surname> <given-names>VG</given-names></name> <name><surname>Stegen</surname> <given-names>JC</given-names></name> <name><surname>Jansson</surname> <given-names>JK</given-names></name> <name><surname>Davison</surname> <given-names>MR</given-names></name></person-group>. <article-title>RNA Viruses linked to eukaryotic hosts in thawed permafrost</article-title>. <source>mSystems</source>. (<year>2022</year>) <volume>7</volume>(<issue>6</issue>):<fpage>e0058222</fpage>. <pub-id pub-id-type="doi">10.1128/msystems.00582-22</pub-id><pub-id pub-id-type="pmid">36453933</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Krafft</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name></person-group>. <article-title>Progress and challenges in infectious disease surveillance and early warning</article-title>. <source>Med Plus</source>. (<year>2025</year>) <volume>2</volume>(<issue>1</issue>):<fpage>100071</fpage>. <pub-id pub-id-type="doi">10.1016/j.medp.2025.100071</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname> <given-names>S</given-names></name> <name><surname>Jasny</surname> <given-names>E</given-names></name> <name><surname>Schmidt</surname> <given-names>KE</given-names></name> <name><surname>Petsch</surname> <given-names>B</given-names></name></person-group>. <article-title>New vaccine technologies to combat outbreak situations</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>1963</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01963</pub-id><pub-id pub-id-type="pmid">30283434</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname> <given-names>T</given-names></name> <name><surname>Sun</surname> <given-names>C</given-names></name> <name><surname>Chang</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>G</given-names></name> <name><surname>Yin</surname> <given-names>X</given-names></name></person-group>. <article-title>mRNA vaccine development for emerging animal and zoonotic diseases</article-title>. <source>Viruses</source>. (<year>2022</year>) <volume>14</volume>(<issue>2</issue>):<fpage>401</fpage>. <pub-id pub-id-type="doi">10.3390/v14020401</pub-id><pub-id pub-id-type="pmid">35215994</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poria</surname> <given-names>R</given-names></name> <name><surname>Kala</surname> <given-names>D</given-names></name> <name><surname>Nagraik</surname> <given-names>R</given-names></name> <name><surname>Dhir</surname> <given-names>Y</given-names></name> <name><surname>Dhir</surname> <given-names>S</given-names></name> <name><surname>Singh</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Vaccine development: current trends and technologies</article-title>. <source>Life Sci</source>. (<year>2024</year>) <volume>336</volume>:<fpage>122331</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2023.122331</pub-id><pub-id pub-id-type="pmid">38070863</pub-id></mixed-citation></ref>
<ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>WZ</given-names></name> <name><surname>Lan</surname> <given-names>YJ</given-names></name> <name><surname>Lyu</surname> <given-names>W</given-names></name> <name><surname>Leng</surname> <given-names>ZW</given-names></name> <name><surname>Feng</surname> <given-names>LZ</given-names></name> <name><surname>Lai</surname> <given-names>SJ</given-names></name><etal/></person-group> <article-title>[Establishment of multi-point trigger and multi-channel surveillance mechanism for intelligent early warning of infectious diseases in China]</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi</source>. (<year>2020</year>) <volume>41</volume>(<issue>11</issue>):<fpage>1753</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn112338-20200722-00972</pub-id><pub-id pub-id-type="pmid">32746606</pub-id></mixed-citation></ref>
<ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><collab>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, School of Public Health, Peking University, Department of Management on Infectious Diseases, Chinese Center for Disease Control and Prevention</collab>. <article-title>Expert consensus on the key technologies for a multi-point trigger intelligent surveillance and early warning system for infectious diseases</article-title>. <source>Zhonghua Yi Xue Za Zhi</source>. (<year>2024</year>) <volume>104</volume>(<issue>32</issue>):<fpage>2995</fpage>&#x2013;<lpage>3009</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn112137-20240612-01317</pub-id><pub-id pub-id-type="pmid">38953126</pub-id></mixed-citation></ref>
<ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClymont</surname> <given-names>H</given-names></name> <name><surname>Bambrick</surname> <given-names>H</given-names></name> <name><surname>Si</surname> <given-names>X</given-names></name> <name><surname>Vardoulakis</surname> <given-names>S</given-names></name> <name><surname>Hu</surname> <given-names>W</given-names></name></person-group>. <article-title>Future perspectives of emerging infectious diseases control: a one health approach</article-title>. <source>One Health</source>. (<year>2022</year>) <volume>14</volume>:<fpage>100371</fpage>. <pub-id pub-id-type="doi">10.1016/j.onehlt.2022.100371</pub-id><pub-id pub-id-type="pmid">35075433</pub-id></mixed-citation></ref>
<ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suu-Ire</surname> <given-names>RD</given-names></name> <name><surname>Obodai</surname> <given-names>E</given-names></name> <name><surname>Bonney</surname> <given-names>JHK</given-names></name> <name><surname>Bel-Nono</surname> <given-names>SO</given-names></name> <name><surname>Ampofo</surname> <given-names>W</given-names></name> <name><surname>Kelly</surname> <given-names>TR</given-names></name></person-group>. <article-title>Viral zoonoses of national importance in Ghana: advancements and opportunities for enhancing capacities for early detection and response</article-title>. <source>J Trop Med</source>. (<year>2021</year>) <volume>2021</volume>:<fpage>8938530</fpage>. <pub-id pub-id-type="doi">10.1155/2021/8938530</pub-id><pub-id pub-id-type="pmid">33574853</pub-id></mixed-citation></ref>
<ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plowright</surname> <given-names>RK</given-names></name> <name><surname>Hudson</surname> <given-names>PJ</given-names></name></person-group>. <article-title>From protein to pandemic: the transdisciplinary approach needed to prevent spillover and the next pandemic</article-title>. <source>Viruses</source>. (<year>2021</year>) <volume>13</volume>(<issue>7</issue>):<fpage>1298</fpage>. <pub-id pub-id-type="doi">10.3390/v13071298</pub-id><pub-id pub-id-type="pmid">34372504</pub-id></mixed-citation></ref>
<ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>TR</given-names></name> <name><surname>Karesh</surname> <given-names>WB</given-names></name> <name><surname>Johnson</surname> <given-names>CK</given-names></name> <name><surname>Gilardi</surname> <given-names>KVK</given-names></name> <name><surname>Anthony</surname> <given-names>SJ</given-names></name> <name><surname>Goldstein</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>One health proof of concept: bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface</article-title>. <source>Prev Vet Med</source>. (<year>2017</year>) <volume>137</volume>(<issue>Pt B</issue>):<fpage>112</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.prevetmed.2016.11.023</pub-id><pub-id pub-id-type="pmid">28034593</pub-id></mixed-citation></ref>
<ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguirre</surname> <given-names>AA</given-names></name> <name><surname>Beasley</surname> <given-names>VR</given-names></name> <name><surname>Augspurger</surname> <given-names>T</given-names></name> <name><surname>Benson</surname> <given-names>WH</given-names></name> <name><surname>Whaley</surname> <given-names>J</given-names></name> <name><surname>Basu</surname> <given-names>N</given-names></name></person-group>. <article-title>One health-transdisciplinary opportunities for SETAC leadership in integrating and improving the health of people, animals, and the environment</article-title>. <source>Environ Toxicol Chem</source>. (<year>2016</year>) <volume>35</volume>(<issue>10</issue>):<fpage>2383</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1002/etc.3557</pub-id><pub-id pub-id-type="pmid">27717067</pub-id></mixed-citation></ref>
<ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname> <given-names>C</given-names></name> <name><surname>Lavenu</surname> <given-names>A</given-names></name> <name><surname>Bertaud</surname> <given-names>V</given-names></name> <name><surname>Campillo-Gimenez</surname> <given-names>B</given-names></name> <name><surname>Chazard</surname> <given-names>E</given-names></name> <name><surname>Cuggia</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Real time influenza monitoring using hospital big data in combination with machine learning methods: comparison study</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2018</year>) <volume>4</volume>(<issue>4</issue>):<fpage>e11361</fpage>. <pub-id pub-id-type="doi">10.2196/11361</pub-id><pub-id pub-id-type="pmid">30578212</pub-id></mixed-citation></ref>
<ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonsen</surname> <given-names>L</given-names></name> <name><surname>Gog</surname> <given-names>JR</given-names></name> <name><surname>Olson</surname> <given-names>D</given-names></name> <name><surname>Viboud</surname> <given-names>C</given-names></name></person-group>. <article-title>Infectious disease surveillance in the big data era: towards faster and locally relevant systems</article-title>. <source>J Infect Dis</source>. (<year>2016</year>) <volume>214</volume>(<issue>suppl_4</issue>):<fpage>S380</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiw376</pub-id><pub-id pub-id-type="pmid">28830112</pub-id></mixed-citation></ref>
<ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouzill&#x00E9;</surname> <given-names>G</given-names></name> <name><surname>Poirier</surname> <given-names>C</given-names></name> <name><surname>Campillo-Gimenez</surname> <given-names>B</given-names></name> <name><surname>Aubert</surname> <given-names>M-L</given-names></name> <name><surname>Chabot</surname> <given-names>M</given-names></name> <name><surname>Chazard</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Leveraging hospital big data to monitor flu epidemics</article-title>. <source>Comput Methods Programs Biomed</source>. (<year>2018</year>) <volume>154</volume>:<fpage>153</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmpb.2017.11.012</pub-id></mixed-citation></ref>
<ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>T</given-names></name> <name><surname>Han</surname> <given-names>X</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Ma</surname> <given-names>L</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Influenza epidemic trend surveillance and prediction based on search engine data: deep learning model study</article-title>. <source>J Med Internet Res</source>. (<year>2023</year>) <volume>25</volume>:<fpage>e45085</fpage>. <pub-id pub-id-type="doi">10.2196/45085</pub-id><pub-id pub-id-type="pmid">37847532</pub-id></mixed-citation></ref>
<ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazer</surname> <given-names>D</given-names></name> <name><surname>Kennedy</surname> <given-names>R</given-names></name> <name><surname>King</surname> <given-names>G</given-names></name> <name><surname>Vespignani</surname> <given-names>A</given-names></name></person-group>. <article-title>The parable of Google Flu: traps in big data analysis</article-title>. <source>Science</source>. (<year>2014</year>) <volume>343</volume>(<issue>6176</issue>):<fpage>1203</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.1248506</pub-id><pub-id pub-id-type="pmid">24626916</pub-id></mixed-citation></ref>
<ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomburg</surname> <given-names>J</given-names></name> <name><surname>Doherty</surname> <given-names>EE</given-names></name> <name><surname>Price</surname> <given-names>N</given-names></name> <name><surname>Bellieny-Rabelo</surname> <given-names>D</given-names></name> <name><surname>Zhu</surname> <given-names>YK</given-names></name> <name><surname>Doudna</surname> <given-names>JA</given-names></name></person-group>. <article-title>Birth of protein folds and functions in the virome</article-title>. <source>Nature</source>. (<year>2024</year>) <volume>633</volume>(<issue>8030</issue>):<fpage>710</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-024-07809-y</pub-id><pub-id pub-id-type="pmid">39187718</pub-id></mixed-citation></ref>
<ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutnik</surname> <given-names>D</given-names></name> <name><surname>Evseev</surname> <given-names>P</given-names></name> <name><surname>Miroshnikov</surname> <given-names>K</given-names></name> <name><surname>Shneider</surname> <given-names>M</given-names></name></person-group>. <article-title>Using AlphaFold predictions in viral research</article-title>. <source>Curr Issues Mol Biol</source>. (<year>2023</year>) <volume>45</volume>(<issue>4</issue>):<fpage>3705</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.3390/cimb45040240</pub-id><pub-id pub-id-type="pmid">37185764</pub-id></mixed-citation></ref>
<ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buhlheller</surname> <given-names>C</given-names></name> <name><surname>Sagmeister</surname> <given-names>T</given-names></name> <name><surname>Grininger</surname> <given-names>C</given-names></name> <name><surname>Gubens&#x00E4;k</surname> <given-names>N</given-names></name> <name><surname>Sleytr</surname> <given-names>UB</given-names></name> <name><surname>Us&#x00F3;n</surname> <given-names>I</given-names></name><etal/></person-group> <article-title>Symprofold: structural prediction of symmetrical biological assemblies</article-title>. <source>Nat Commun</source>. (<year>2024</year>) <volume>15</volume>(<issue>1</issue>):<fpage>8152</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-52138-3</pub-id><pub-id pub-id-type="pmid">39294115</pub-id></mixed-citation></ref>
<ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegally</surname> <given-names>H</given-names></name> <name><surname>San</surname> <given-names>JE</given-names></name> <name><surname>Cotten</surname> <given-names>M</given-names></name> <name><surname>Moir</surname> <given-names>M</given-names></name> <name><surname>Tegomoh</surname> <given-names>B</given-names></name> <name><surname>Mboowa</surname> <given-names>G</given-names></name><etal/></person-group> <article-title>The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance</article-title>. <source>Science</source>. (<year>2022</year>) <volume>378</volume>(<issue>6615</issue>):<fpage>eabq5358</fpage>. <pub-id pub-id-type="doi">10.1126/science.abq5358</pub-id><pub-id pub-id-type="pmid">36108049</pub-id></mixed-citation></ref>
<ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkmann</surname> <given-names>A</given-names></name> <name><surname>Ulm</surname> <given-names>SL</given-names></name> <name><surname>Uddin</surname> <given-names>S</given-names></name> <name><surname>F&#x00F6;rster</surname> <given-names>S</given-names></name> <name><surname>Seifert</surname> <given-names>D</given-names></name> <name><surname>Oehme</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Amplicov: rapid whole-genome sequencing using Multiplex PCR amplification and real-time Oxford nanopore MinION sequencing enables rapid variant identification of SARS-CoV-2</article-title>. <source>Front Microbiol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>651151</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.651151</pub-id><pub-id pub-id-type="pmid">34276587</pub-id></mixed-citation></ref>
<ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwalbe</surname> <given-names>N</given-names></name> <name><surname>Wahl</surname> <given-names>B</given-names></name></person-group>. <article-title>Artificial intelligence and the future of global health</article-title>. <source>Lancet Lond Engl</source>. (<year>2020</year>) <volume>395</volume>(<issue>10236</issue>):<fpage>1579</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30226-9</pub-id></mixed-citation></ref>
<ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodosiou</surname> <given-names>AA</given-names></name> <name><surname>Read</surname> <given-names>RC</given-names></name></person-group>. <article-title>Artificial intelligence, machine learning and deep learning: potential resources for the infection clinician</article-title>. <source>J Infect</source>. (<year>2023</year>) <volume>87</volume>(<issue>4</issue>):<fpage>287</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2023.07.006</pub-id><pub-id pub-id-type="pmid">37468046</pub-id></mixed-citation></ref>
<ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>BE</given-names></name> <name><surname>Chen</surname> <given-names>DTY</given-names></name> <name><surname>Ponnudurai</surname> <given-names>K</given-names></name> <name><surname>Winkler</surname> <given-names>S</given-names></name></person-group>. <article-title>Artificial intelligence for malaria: bridging the gap for real world usage</article-title>. <source>Lancet Reg Health Southeast Asia</source>. (<year>2022</year>) <volume>5</volume>:<fpage>100073</fpage>. <pub-id pub-id-type="doi">10.1016/j.lansea.2022.100073</pub-id><pub-id pub-id-type="pmid">37383664</pub-id></mixed-citation></ref>
<ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownstein</surname> <given-names>JS</given-names></name> <name><surname>Rader</surname> <given-names>B</given-names></name> <name><surname>Astley</surname> <given-names>CM</given-names></name> <name><surname>Tian</surname> <given-names>H</given-names></name></person-group>. <article-title>Advances in artificial intelligence for infectious-disease surveillance</article-title>. <source>N Engl J Med</source>. (<year>2023</year>) <volume>388</volume>(<issue>17</issue>):<fpage>1597</fpage>&#x2013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra2119215</pub-id><pub-id pub-id-type="pmid">37099342</pub-id></mixed-citation></ref>
<ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>F</given-names></name> <name><surname>de la Fuente-Nunez</surname> <given-names>C</given-names></name> <name><surname>Collins</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Leveraging artificial intelligence in the fight against infectious diseases</article-title>. <source>Science</source>. (<year>2023</year>) <volume>381</volume>(<issue>6654</issue>):<fpage>164</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1126/science.adh1114</pub-id><pub-id pub-id-type="pmid">37440620</pub-id></mixed-citation></ref>
<ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname> <given-names>RA</given-names></name> <name><surname>Thornton</surname> <given-names>JM</given-names></name></person-group>. <article-title>PDBsum extras: sARS-CoV-2 and AlphaFold models</article-title>. <source>Protein Sci Publ Protein Soc</source>. (<year>2022</year>) <volume>31</volume>(<issue>1</issue>):<fpage>283</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/pro.4238</pub-id></mixed-citation></ref>
<ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname> <given-names>MA</given-names></name> <name><surname>Caetano-Anoll&#x00E9;s</surname> <given-names>G</given-names></name></person-group>. <article-title>Alphafold2 reveals structural patterns of seasonal haplotype diversification in SARS-CoV-2 spike protein variants</article-title>. <source>Biology (Basel)</source>. (<year>2024</year>) <volume>13</volume>(<issue>3</issue>):<fpage>134</fpage>. <pub-id pub-id-type="doi">10.3390/biology13030134</pub-id><pub-id pub-id-type="pmid">38534404</pub-id></mixed-citation></ref>
<ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trepte</surname> <given-names>P</given-names></name> <name><surname>Secker</surname> <given-names>C</given-names></name> <name><surname>Olivet</surname> <given-names>J</given-names></name> <name><surname>Blavier</surname> <given-names>J</given-names></name> <name><surname>Kostova</surname> <given-names>S</given-names></name> <name><surname>Maseko</surname> <given-names>SB</given-names></name><etal/></person-group> <article-title>AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor</article-title>. <source>Mol Syst Biol</source>. (<year>2024</year>) <volume>20</volume>(<issue>4</issue>):<fpage>428</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/s44320-024-00019-8</pub-id><pub-id pub-id-type="pmid">38467836</pub-id></mixed-citation></ref>
<ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname> <given-names>B</given-names></name></person-group>. <article-title><italic>De novo</italic> protein folding on computers. Benefits and challenges</article-title>. <source>Comput Biol Med</source>. (<year>2022</year>) <volume>143</volume>:<fpage>105292</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.105292</pub-id><pub-id pub-id-type="pmid">35158120</pub-id></mixed-citation></ref>
<ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dananjayan</surname> <given-names>S</given-names></name> <name><surname>Raj</surname> <given-names>GM</given-names></name></person-group>. <article-title>Artificial intelligence during a pandemic: the COVID-19 example</article-title>. <source>Int J Health Plann Manage</source>. (<year>2020</year>) <volume>35</volume>(<issue>5</issue>):<fpage>1260</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1002/hpm.2987</pub-id><pub-id pub-id-type="pmid">32430976</pub-id></mixed-citation></ref>
<ref id="B48"><label>48.</label><mixed-citation publication-type="other"><comment>Department of Medicine, Temerty Faculty of Medicine, University of Toronto. Tracking the Coronavirus Pandemic with AI: BlueDot featured on 60 Minutes. (2020). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://deptmedicine.utoronto.ca/news/tracking-coronavirus-pandemic-ai-bluedot-featured-60-minutes">https://deptmedicine.utoronto.ca/news/tracking-coronavirus-pandemic-ai-bluedot-featured-60-minutes</ext-link> <comment>(Accessed June 17, 2025)</comment>.</mixed-citation></ref>
<ref id="B49"><label>49.</label><mixed-citation publication-type="other"><collab>How Bluedot Identified Covid-19 Before Health Authorities</collab>. <comment>How Bluedot Identified Covid-19 Before Health Authorities</comment> (<year>2020</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.deeplearning.ai/the-batch/stopping-coronavirus/">https://www.deeplearning.ai/the-batch/stopping-coronavirus/</ext-link> <comment>(Accessed June 17, 2025)</comment>.</mixed-citation></ref>
<ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodaei</surname> <given-names>A</given-names></name> <name><surname>Eskandari</surname> <given-names>S</given-names></name> <name><surname>Sharifi</surname> <given-names>H</given-names></name> <name><surname>Mozaffari-Tazehkand</surname> <given-names>B</given-names></name></person-group>. <article-title>PRCFX-DT: a new graph-based approach for feature selection and classification of genomic sequences</article-title>. <source>BMC Bioinformatics</source>. (<year>2025</year>) <volume>26</volume>(<issue>1</issue>):<fpage>159</fpage>. <pub-id pub-id-type="doi">10.1186/s12859-025-06183-4</pub-id><pub-id pub-id-type="pmid">40528202</pub-id></mixed-citation></ref>
<ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Quick</surname> <given-names>C</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Gaynor</surname> <given-names>SM</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Powerful, scalable and resource-efficient meta-analysis of rare variant associations in large whole genome sequencing studies</article-title>. <source>Nat Genet</source>. (<year>2023</year>) <volume>55</volume>(<issue>1</issue>):<fpage>154</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-022-01225-6</pub-id><pub-id pub-id-type="pmid">36564505</pub-id></mixed-citation></ref>
<ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Pol</surname> <given-names>Y</given-names></name> <name><surname>Tantyo</surname> <given-names>NA</given-names></name> <name><surname>Evander</surname> <given-names>N</given-names></name> <name><surname>Hentschel</surname> <given-names>AE</given-names></name> <name><surname>Wever</surname> <given-names>BM</given-names></name> <name><surname>Ramaker</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing</article-title>. <source>EMBO Mol Med</source>. (<year>2023</year>) <volume>15</volume>(<issue>12</issue>):<fpage>e17282</fpage>. <pub-id pub-id-type="doi">10.15252/emmm.202217282</pub-id><pub-id pub-id-type="pmid">37942753</pub-id></mixed-citation></ref>
<ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melarkode</surname> <given-names>N</given-names></name> <name><surname>Srinivasan</surname> <given-names>K</given-names></name> <name><surname>Qaisar</surname> <given-names>SM</given-names></name> <name><surname>Plawiak</surname> <given-names>P</given-names></name></person-group>. <article-title>AI-Powered Diagnosis of skin cancer: a contemporary review, open challenges and future research directions</article-title>. <source>Cancers (Basel)</source>. (<year>2023</year>) <volume>15</volume>(<issue>4</issue>):<fpage>1183</fpage>. <pub-id pub-id-type="doi">10.3390/cancers15041183</pub-id><pub-id pub-id-type="pmid">36831525</pub-id></mixed-citation></ref>
<ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>X</given-names></name> <name><surname>Rushlow</surname> <given-names>DR</given-names></name> <name><surname>Inselman</surname> <given-names>JW</given-names></name> <name><surname>McCoy</surname> <given-names>RG</given-names></name> <name><surname>Thacher</surname> <given-names>TD</given-names></name> <name><surname>Behnken</surname> <given-names>EM</given-names></name><etal/></person-group> <article-title>Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial</article-title>. <source>Nat Med</source>. (<year>2021</year>) <volume>27</volume>(<issue>5</issue>):<fpage>815</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-021-01335-4</pub-id><pub-id pub-id-type="pmid">33958795</pub-id></mixed-citation></ref>
<ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amendola</surname> <given-names>G</given-names></name> <name><surname>Cosconati</surname> <given-names>S</given-names></name></person-group>. <article-title>PyRMD: a new fully automated AI-powered ligand-based virtual screening tool</article-title>. <source>J Chem Inf Model</source>. (<year>2021</year>) <volume>61</volume>(<issue>8</issue>):<fpage>3835</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.1c00653</pub-id><pub-id pub-id-type="pmid">34270903</pub-id></mixed-citation></ref>
<ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>M</given-names></name> <name><surname>Wojtusciszyn</surname> <given-names>A</given-names></name> <name><surname>Favre</surname> <given-names>L</given-names></name> <name><surname>Boughorbel</surname> <given-names>S</given-names></name> <name><surname>Shan</surname> <given-names>J</given-names></name> <name><surname>Letaief</surname> <given-names>KB</given-names></name><etal/></person-group> <article-title>Precision medicine in the era of artificial intelligence: implications in chronic disease management</article-title>. <source>J Transl Med</source>. (<year>2020</year>) <volume>18</volume>(<issue>1</issue>):<fpage>472</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-020-02658-5</pub-id><pub-id pub-id-type="pmid">33298113</pub-id></mixed-citation></ref>
<ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okpete</surname> <given-names>UE</given-names></name> <name><surname>Byeon</surname> <given-names>H</given-names></name></person-group>. <article-title>Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment</article-title>. <source>World J Psychiatry</source>. (<year>2024</year>) <volume>14</volume>(<issue>8</issue>):<fpage>1148</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.5498/wjp.v14.i8.1148</pub-id><pub-id pub-id-type="pmid">39165556</pub-id></mixed-citation></ref>
<ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shade</surname> <given-names>M</given-names></name> <name><surname>Yan</surname> <given-names>C</given-names></name> <name><surname>Jones</surname> <given-names>VK</given-names></name> <name><surname>Boron</surname> <given-names>J</given-names></name></person-group>. <article-title>Evaluating older Adults&#x2019; engagement and usability with AI-driven interventions: randomized pilot study</article-title>. <source>JMIR Form Res</source>. (<year>2025</year>) <volume>9</volume>:<fpage>e64763</fpage>. <pub-id pub-id-type="doi">10.2196/64763</pub-id><pub-id pub-id-type="pmid">39865552</pub-id></mixed-citation></ref>
<ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaishya</surname> <given-names>R</given-names></name> <name><surname>Javaid</surname> <given-names>M</given-names></name> <name><surname>Khan</surname> <given-names>IH</given-names></name> <name><surname>Haleem</surname> <given-names>A</given-names></name></person-group>. <article-title>Artificial intelligence (AI) applications for COVID-19 pandemic</article-title>. <source>Diabetes Metab Syndr</source>. (<year>2020</year>) <volume>14</volume>(<issue>4</issue>):<fpage>337</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.dsx.2020.04.012</pub-id><pub-id pub-id-type="pmid">32305024</pub-id></mixed-citation></ref>
<ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Morr</surname> <given-names>C</given-names></name> <name><surname>Ozdemir</surname> <given-names>D</given-names></name> <name><surname>Asdaah</surname> <given-names>Y</given-names></name> <name><surname>Saab</surname> <given-names>A</given-names></name> <name><surname>El-Lahib</surname> <given-names>Y</given-names></name> <name><surname>Sokhn</surname> <given-names>ES</given-names></name></person-group>. <article-title>AI-based epidemic and pandemic early warning systems: a systematic scoping review</article-title>. <source>Health Informatics J</source>. (<year>2024</year>) <volume>30</volume>(<issue>3</issue>):<fpage>14604582241275844</fpage>. <pub-id pub-id-type="doi">10.1177/14604582241275844</pub-id><pub-id pub-id-type="pmid">39172555</pub-id></mixed-citation></ref>
<ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheili</surname> <given-names>M</given-names></name> <name><surname>Khateri</surname> <given-names>S</given-names></name> <name><surname>Moradpour</surname> <given-names>F</given-names></name> <name><surname>Mohammadzedeh</surname> <given-names>P</given-names></name> <name><surname>Zareie</surname> <given-names>M</given-names></name> <name><surname>Mortazavi</surname> <given-names>SMM</given-names></name><etal/></person-group> <article-title>The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. (<year>2023</year>) <volume>22</volume>(<issue>1</issue>):<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s12941-023-00594-y</pub-id><pub-id pub-id-type="pmid">37208749</pub-id></mixed-citation></ref>
<ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>A</given-names></name></person-group>. <article-title>Eliciting B cell immunity against infectious diseases using nanovaccines</article-title>. <source>Nat Nanotechnol</source>. (<year>2021</year>) <volume>16</volume>(<issue>1</issue>):<fpage>16</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/s41565-020-00790-3</pub-id><pub-id pub-id-type="pmid">33199883</pub-id></mixed-citation></ref>
<ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayan</surname> <given-names>V</given-names></name> <name><surname>Mohapatra</surname> <given-names>A</given-names></name> <name><surname>Uthaman</surname> <given-names>S</given-names></name> <name><surname>Park</surname> <given-names>IK</given-names></name></person-group>. <article-title>Recent advances in nanovaccines using biomimetic immunomodulatory materials</article-title>. <source>Pharmaceutics</source>. (<year>2019</year>) <volume>11</volume>(<issue>10</issue>):<fpage>534</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics11100534</pub-id><pub-id pub-id-type="pmid">31615112</pub-id></mixed-citation></ref>
<ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname> <given-names>U</given-names></name> <name><surname>T&#x00FC;reci</surname> <given-names>&#x00D6;</given-names></name></person-group>. <article-title>Personalized vaccines for cancer immunotherapy</article-title>. <source>Science</source>. (<year>2018</year>) <volume>359</volume>(<issue>6382</issue>):<fpage>1355</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1126/science.aar7112</pub-id><pub-id pub-id-type="pmid">29567706</pub-id></mixed-citation></ref>
<ref id="B65"><label>65.</label><mixed-citation publication-type="other"><comment>Bourla A. Moonshot: Inside Pfizer&#x2019;s Nine-month Race to Make the Impossible Possible. eBooks.com. (2022). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.ebooks.com/en-us/book/210284907/moonshot-inside-pfizer-s-nine-month-race-to-make-the-impossible-possible/albert-bourla/">https://www.ebooks.com/en-us/book/210284907/moonshot-inside-pfizer-s-nine-month-race-to-make-the-impossible-possible/albert-bourla/</ext-link> <comment>(Accessed June 19, 2025)</comment>.</mixed-citation></ref>
<ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kis</surname> <given-names>Z</given-names></name> <name><surname>Kontoravdi</surname> <given-names>C</given-names></name> <name><surname>Shattock</surname> <given-names>R</given-names></name> <name><surname>Shah</surname> <given-names>N</given-names></name></person-group>. <article-title>Resources, production scales and time required for producing RNA vaccines for the global pandemic demand</article-title>. <source>Vaccines (Basel)</source>. (<year>2020</year>) <volume>9</volume>(<issue>1</issue>):<fpage>3</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines9010003</pub-id><pub-id pub-id-type="pmid">33374802</pub-id></mixed-citation></ref>
<ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorn</surname> <given-names>CR</given-names></name> <name><surname>Sharma</surname> <given-names>D</given-names></name> <name><surname>Combs</surname> <given-names>R</given-names></name> <name><surname>Bhujbal</surname> <given-names>S</given-names></name> <name><surname>Romine</surname> <given-names>J</given-names></name> <name><surname>Zheng</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>The journey of a lifetime &#x2014; development of Pfizer&#x2019;s COVID-19 vaccine</article-title>. <source>Curr Opin Biotechnol</source>. (<year>2022</year>) <volume>78</volume>:<fpage>102803</fpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2022.102803</pub-id><pub-id pub-id-type="pmid">36162187</pub-id></mixed-citation></ref>
<ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouglas</surname> <given-names>D</given-names></name> <name><surname>Thanh Le</surname> <given-names>T</given-names></name> <name><surname>Henderson</surname> <given-names>K</given-names></name> <name><surname>Kaloudis</surname> <given-names>A</given-names></name> <name><surname>Danielsen</surname> <given-names>T</given-names></name> <name><surname>Hammersland</surname> <given-names>NC</given-names></name><etal/></person-group> <article-title>Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study</article-title>. <source>Lancet Glob Health</source>. (<year>2018</year>) <volume>6</volume>(<issue>12</issue>):<fpage>e1386</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(18)30346-2</pub-id><pub-id pub-id-type="pmid">30342925</pub-id></mixed-citation></ref>
<ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanekiyo</surname> <given-names>M</given-names></name> <name><surname>Wei</surname> <given-names>CJ</given-names></name> <name><surname>Yassine</surname> <given-names>HM</given-names></name> <name><surname>McTamney</surname> <given-names>PM</given-names></name> <name><surname>Boyington</surname> <given-names>JC</given-names></name> <name><surname>Whittle</surname> <given-names>JRR</given-names></name><etal/></person-group> <article-title>Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>499</volume>(<issue>7456</issue>):<fpage>102</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature12202</pub-id><pub-id pub-id-type="pmid">23698367</pub-id></mixed-citation></ref>
<ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyoglu-Barnum</surname> <given-names>S</given-names></name> <name><surname>Ellis</surname> <given-names>D</given-names></name> <name><surname>Gillespie</surname> <given-names>RA</given-names></name> <name><surname>Hutchinson</surname> <given-names>GB</given-names></name> <name><surname>Park</surname> <given-names>Y-J</given-names></name> <name><surname>Moin</surname> <given-names>SM</given-names></name><etal/></person-group> <article-title>Quadrivalent influenza nanoparticle vaccines induce broad protection</article-title>. <source>Nature</source>. (<year>2021</year>) <volume>592</volume>(<issue>7855</issue>):<fpage>623</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03365-x</pub-id><pub-id pub-id-type="pmid">33762730</pub-id></mixed-citation></ref>
<ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arevalo</surname> <given-names>CP</given-names></name> <name><surname>Bolton</surname> <given-names>MJ</given-names></name> <name><surname>Le Sage</surname> <given-names>V</given-names></name> <name><surname>Ye</surname> <given-names>N</given-names></name> <name><surname>Furey</surname> <given-names>C</given-names></name> <name><surname>Muramatsu</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes</article-title>. <source>Science</source>. (<year>2022</year>) <volume>378</volume>(<issue>6622</issue>):<fpage>899</fpage>&#x2013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1126/science.abm0271</pub-id><pub-id pub-id-type="pmid">36423275</pub-id></mixed-citation></ref>
<ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>Zhang</surname> <given-names>FN</given-names></name> <name><surname>Dai</surname> <given-names>H</given-names></name> <name><surname>Jiao</surname> <given-names>X-y</given-names></name> <name><surname>Yu</surname> <given-names>Q-w</given-names></name><etal/></person-group> <article-title>Sensors for surveillance of RNA viruses: a one health perspective</article-title>. <source>Lancet Microbe</source>. (<year>2025</year>) <volume>6</volume>(<issue>6</issue>):<fpage>101029</fpage>. <pub-id pub-id-type="doi">10.1016/j.lanmic.2024.101029</pub-id><pub-id pub-id-type="pmid">39681124</pub-id></mixed-citation></ref>
<ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafa</surname> <given-names>A</given-names></name> <name><surname>Naguib</surname> <given-names>MM</given-names></name> <name><surname>Nogales</surname> <given-names>A</given-names></name> <name><surname>Barre</surname> <given-names>RS</given-names></name> <name><surname>Stewart</surname> <given-names>JP</given-names></name> <name><surname>Garc&#x00ED;a-Sastre</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission</article-title>. <source>mBio</source>. (<year>2024</year>) <volume>15</volume>(<issue>12</issue>):<fpage>e0254224</fpage>. <pub-id pub-id-type="doi">10.1128/mbio.02542-24</pub-id><pub-id pub-id-type="pmid">39535188</pub-id></mixed-citation></ref>
<ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>E</given-names></name></person-group>. <article-title>WHO Introduces worldwide pathogen surveillance network</article-title>. <source>JAMA</source>. (<year>2023</year>) <volume>329</volume>(<issue>23</issue>):<fpage>2012</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2023.9605</pub-id></mixed-citation></ref>
<ref id="B75"><label>75.</label><mixed-citation publication-type="other"><comment>International Pathogen Surveillance Network (IPSN). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.who.int/initiatives/international-pathogen-surveillance-network">https://www.who.int/initiatives/international-pathogen-surveillance-network</ext-link> <comment>(Accessed June 20, 2025)</comment>.</mixed-citation></ref>
<ref id="B76"><label>76.</label><mixed-citation publication-type="other"><comment>Revised draft of the negotiating text of the WHO Pandemic Agreement. (2024). Available online at: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/gb/inb/pdf_files/inb9/A_inb9_3-en.pdf">https://apps.who.int/gb/inb/pdf_files/inb9/A_inb9_3-en.pdf</ext-link> (Accessed June 20, 2025).</comment></mixed-citation></ref>
<ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzelac</surname> <given-names>G</given-names></name> <name><surname>Carol</surname> <given-names>S</given-names></name> <name><surname>David</surname> <given-names>L</given-names></name> <name><surname>Male&#x0161;evi&#x0107;</surname> <given-names>S</given-names></name></person-group>. <article-title>My country first&#x201D;: vaccine nationalism in England?</article-title> <source>Natl Ethn Polit</source>. (<year>2024</year>) <volume>30</volume>(<issue>3</issue>):<fpage>335</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1080/13537113.2023.2285088</pub-id></mixed-citation></ref>
<ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesce</surname> <given-names>M</given-names></name> <name><surname>Feikin</surname> <given-names>DR</given-names></name> <name><surname>Higdon</surname> <given-names>MM</given-names></name> <name><surname>O&#x2019;Brien</surname> <given-names>KL</given-names></name> <name><surname>Patel</surname> <given-names>MK</given-names></name> <name><surname>Rearte</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines</article-title>. <source>Nat Commun</source>. (<year>2025</year>) <volume>16</volume>(<issue>1</issue>):<fpage>9059</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-025-63950-w</pub-id><pub-id pub-id-type="pmid">41083450</pub-id></mixed-citation></ref>
<ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Eitan</surname> <given-names>LN</given-names></name> <name><surname>Almahdawi</surname> <given-names>DL</given-names></name> <name><surname>Abu Khiarah</surname> <given-names>RA</given-names></name> <name><surname>Alghamdi</surname> <given-names>MA</given-names></name></person-group>. <article-title>Bridging gaps in vaccine access and equity: a middle eastern perspective</article-title>. <source>Vaccines (Basel)</source>. (<year>2025</year>) <volume>13</volume>(<issue>8</issue>):<fpage>806</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines13080806</pub-id><pub-id pub-id-type="pmid">40872893</pub-id></mixed-citation></ref>
<ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khare</surname> <given-names>S</given-names></name> <name><surname>Gurry</surname> <given-names>C</given-names></name> <name><surname>Freitas</surname> <given-names>L</given-names></name> <name><surname>B Schultz</surname> <given-names>M</given-names></name> <name><surname>Bach</surname> <given-names>G</given-names></name> <name><surname>Diallo</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>GISAID&#x2019;s role in pandemic response</article-title>. <source>China CDC wkly</source>. (<year>2021</year>) <volume>3</volume>(<issue>49</issue>):<fpage>1049</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.46234/ccdcw2021.255</pub-id><pub-id pub-id-type="pmid">34934514</pub-id></mixed-citation></ref>
<ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>K</given-names></name> <name><surname>Melnychuk</surname> <given-names>S</given-names></name> <name><surname>Sandstrom</surname> <given-names>P</given-names></name> <name><surname>Ji</surname> <given-names>H</given-names></name></person-group>. <article-title>Tracking the evolution of the SARS-CoV-2 Delta variant of concern: analysis of genetic diversity and selection across the whole viral genome</article-title>. <source>Front Microbiol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1222301</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2023.1222301</pub-id><pub-id pub-id-type="pmid">37614597</pub-id></mixed-citation></ref>
<ref id="B82"><label>82.</label><mixed-citation publication-type="other"><comment>A Network-on-Chip Accelerator for Genome Variant Analysis &#x007C; IEEE Conference Publication &#x007C; IEEE Xplore. (2019). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://ieeexplore.ieee.org/document/8621237">https://ieeexplore.ieee.org/document/8621237</ext-link> <comment>(Accessed June 20, 2025)</comment>.</mixed-citation></ref>
<ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname> <given-names>D</given-names></name> <name><surname>Brown</surname> <given-names>GW</given-names></name> <name><surname>Oyibo</surname> <given-names>WA</given-names></name> <name><surname>Ou&#x00E9;draogo</surname> <given-names>S</given-names></name> <name><surname>Tacheva</surname> <given-names>B</given-names></name> <name><surname>Barbaud</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>COVAX&#x2014;time to reconsider the strategy and its target</article-title>. <source>Health Policy OPEN</source>. (<year>2023</year>) <volume>4</volume>:<fpage>100096</fpage>. <pub-id pub-id-type="doi">10.1016/j.hpopen.2023.100096</pub-id><pub-id pub-id-type="pmid">37073303</pub-id></mixed-citation></ref>
<ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnsley</surname> <given-names>G</given-names></name> <name><surname>Mesa</surname> <given-names>DO</given-names></name> <name><surname>Hogan</surname> <given-names>AB</given-names></name> <name><surname>Olivera Mesa</surname> <given-names>D</given-names></name> <name><surname>Winskill</surname> <given-names>P</given-names></name> <name><surname>Torkelson</surname> <given-names>AA</given-names></name><etal/></person-group> <article-title>Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study</article-title>. <source>Lancet Glob Health</source>. (<year>2024</year>) <volume>12</volume>(<issue>11</issue>):<fpage>e1764</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(24)00286-9</pub-id><pub-id pub-id-type="pmid">39424569</pub-id></mixed-citation></ref>
<ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usher</surname> <given-names>AD</given-names></name></person-group>. <article-title>CEPI Launches 100-day vaccine &#x201C;moonshot.&#x201D;</article-title>. <source>Lancet</source>. (<year>2022</year>) <volume>399</volume>(<issue>10330</issue>):<fpage>1107</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(22)00513-X</pub-id><pub-id pub-id-type="pmid">35305730</pub-id></mixed-citation></ref>
<ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budak</surname> <given-names>C</given-names></name> <name><surname>Nyhan</surname> <given-names>B</given-names></name> <name><surname>Rothschild</surname> <given-names>DM</given-names></name> <name><surname>Thorson</surname> <given-names>E</given-names></name> <name><surname>Watts</surname> <given-names>DJ</given-names></name></person-group>. <article-title>Misunderstanding the harms of online misinformation</article-title>. <source>Nature</source>. (<year>2024</year>) <volume>630</volume>(<issue>8015</issue>):<fpage>45</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-024-07417-w</pub-id><pub-id pub-id-type="pmid">38840013</pub-id></mixed-citation></ref>
<ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><collab>What we do - and don&#x0027;t - know about how misinformation spreads online</collab>. <source>Nature</source>. (<year>2024</year>) <volume>630</volume>(<issue>8015</issue>):<fpage>7</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-024-01618-z</pub-id><pub-id pub-id-type="pmid">38840017</pub-id></mixed-citation></ref>
<ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HK</given-names></name> <name><surname>Tandoc</surname> <given-names>EC</given-names></name></person-group>. <article-title>Consequences of online misinformation on COVID-19: two potential pathways and disparity by eHealth literacy</article-title>. <source>Front Psychol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>783909</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2022.783909</pub-id><pub-id pub-id-type="pmid">35237207</pub-id></mixed-citation></ref>
<ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Presti</surname> <given-names>S</given-names></name> <name><surname>Mattavelli</surname> <given-names>G</given-names></name> <name><surname>Canessa</surname> <given-names>N</given-names></name> <name><surname>Gianelli</surname> <given-names>C</given-names></name></person-group>. <article-title>Psychological precursors of individual differences in COVID-19 lockdown adherence: moderated-moderation by personality and moral cognition measures</article-title>. <source>Personal Individ Differ</source>. (<year>2021</year>) <volume>182</volume>:<fpage>111090</fpage>. <pub-id pub-id-type="doi">10.1016/j.paid.2021.111090</pub-id></mixed-citation></ref>
<ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname> <given-names>AM</given-names></name> <name><surname>Vestergren</surname> <given-names>S</given-names></name></person-group>. <article-title>COVIDiSTRESS diverse dataset on psychological and behavioural outcomes one year into the COVID-19 pandemic</article-title>. <source>Sci Data</source>. (<year>2022</year>) <volume>9</volume>(<issue>1</issue>):<fpage>331</fpage>. <pub-id pub-id-type="doi">10.1038/s41597-022-01383-6</pub-id><pub-id pub-id-type="pmid">35729305</pub-id></mixed-citation></ref>
<ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kritzinger</surname> <given-names>S</given-names></name> <name><surname>Foucault</surname> <given-names>M</given-names></name> <name><surname>Lachat</surname> <given-names>R</given-names></name> <name><surname>Partheym&#x00FC;ller</surname> <given-names>J</given-names></name> <name><surname>Plescia</surname> <given-names>C</given-names></name> <name><surname>Brouard</surname> <given-names>S</given-names></name></person-group>. <article-title>&#x2018;Rally round the flag&#x2019;: the COVID-19 crisis and trust in the national government</article-title>. <source>West Eur Polit</source>. (<year>2021</year>) <volume>44</volume>(<issue>5-6</issue>):<fpage>1205</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1080/01402382.2021.1925017</pub-id></mixed-citation></ref>
<ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x00F8;rensen</surname> <given-names>JFL</given-names></name> <name><surname>Christiansen</surname> <given-names>M</given-names></name></person-group>. <article-title>The role of economic stress, health concerns, and institutional trust in supporting public protests against COVID-19 lockdown measures in Denmark</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2022</year>) <volume>20</volume>(<issue>1</issue>):<fpage>148</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph20010148</pub-id></mixed-citation></ref>
<ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenship</surname> <given-names>EB</given-names></name> <name><surname>Goff</surname> <given-names>ME</given-names></name> <name><surname>Yin</surname> <given-names>J</given-names></name> <name><surname>Tse</surname> <given-names>ZTH</given-names></name> <name><surname>Fu</surname> <given-names>K-W</given-names></name> <name><surname>Liang</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Sentiment, contents, and retweets: a study of two vaccine-related twitter datasets</article-title>. <source>Perm J</source>. (<year>2018</year>) <volume>22</volume>:<fpage>17</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.7812/TPP/17-138</pub-id><pub-id pub-id-type="pmid">29911966</pub-id></mixed-citation></ref>
<ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sell</surname> <given-names>TK</given-names></name> <name><surname>Hosangadi</surname> <given-names>D</given-names></name> <name><surname>Trotochaud</surname> <given-names>M</given-names></name></person-group>. <article-title>Misinformation and the US Ebola communication crisis: analyzing the veracity and content of social media messages related to a fear-inducing infectious disease outbreak</article-title>. <source>BMC Public Health</source>. (<year>2020</year>) <volume>20</volume>(<issue>1</issue>):<fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-020-08697-3</pub-id><pub-id pub-id-type="pmid">32375715</pub-id></mixed-citation></ref>
<ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scannell</surname> <given-names>D</given-names></name> <name><surname>Desens</surname> <given-names>L</given-names></name> <name><surname>Guadagno</surname> <given-names>M</given-names></name> <name><surname>Tra</surname> <given-names>Y</given-names></name> <name><surname>Acker</surname> <given-names>E</given-names></name> <name><surname>Sheridan</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>COVID-19 Vaccine discourse on twitter: a content analysis of persuasion techniques, sentiment and mis/disinformation</article-title>. <source>J Health Commun</source>. (<year>2021</year>) <volume>26</volume>(<issue>7</issue>):<fpage>443</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1080/10810730.2021.1955050</pub-id><pub-id pub-id-type="pmid">34346288</pub-id></mixed-citation></ref>
<ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname> <given-names>A</given-names></name> <name><surname>West</surname> <given-names>J</given-names></name></person-group>. <article-title>Conditional cash lotteries increase COVID-19 vaccination rates</article-title>. <source>J Health Econ</source>. (<year>2022</year>) <volume>81</volume>:<fpage>102578</fpage>. <pub-id pub-id-type="doi">10.1016/j.jhealeco.2021.102578</pub-id><pub-id pub-id-type="pmid">34986437</pub-id></mixed-citation></ref>
<ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname> <given-names>ZM</given-names></name></person-group>. <article-title>Everyone wins: vaccine lotteries can cost-effectively increase COVID-19 booster vaccination rates</article-title>. <source>Am J Epidemiol</source>. (<year>2023</year>) <volume>192</volume>(<issue>4</issue>):<fpage>510</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwad013</pub-id><pub-id pub-id-type="pmid">36642497</pub-id></mixed-citation></ref>
<ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardi</surname> <given-names>P</given-names></name> <name><surname>Djalalinia</surname> <given-names>S</given-names></name> <name><surname>Kargar</surname> <given-names>R</given-names></name> <name><surname>Jamee</surname> <given-names>M</given-names></name> <name><surname>Esmaeili Abdar</surname> <given-names>Z</given-names></name> <name><surname>Qorbani</surname> <given-names>M</given-names></name></person-group>. <article-title>Impact of incentives on COVID-19 vaccination; A systematic review</article-title>. <source>Front Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>810323</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2022.810323</pub-id></mixed-citation></ref>
<ref id="B99"><label>99.</label><mixed-citation publication-type="other"><collab>EPI-WIN</collab>. <comment>&#x00A0;Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.who.int/teams/epi-win">https://www.who.int/teams/epi-win</ext-link> <comment>(Accessed June 23, 2025)</comment>.</mixed-citation></ref>
<ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Qiu</surname> <given-names>X</given-names></name></person-group>. <article-title>Risk perception in different COVID-19 stages: the predictive role of cultural orientation</article-title>. <source>Int J Intercult Relat</source>. (<year>2025</year>) <volume>105</volume>:<fpage>102123</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijintrel.2024.102123</pub-id></mixed-citation></ref>
<ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>S</given-names></name> <name><surname>Kim</surname> <given-names>S</given-names></name> <name><surname>Lee</surname> <given-names>J</given-names></name> <name><surname>Heo</surname> <given-names>B</given-names></name></person-group>. <article-title>Evolving norms: social media data analysis on parks and greenspaces perception changes before and after the COVID 19 pandemic using a machine learning approach</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>(<issue>1</issue>):<fpage>13246</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-17077-3</pub-id><pub-id pub-id-type="pmid">35918495</pub-id></mixed-citation></ref>
<ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andr&#x00E9;</surname> <given-names>FE</given-names></name></person-group>. <article-title>Development and clinical application of new polyvalent combined paediatric vaccines</article-title>. <source>Vaccine</source>. (<year>1999</year>) <volume>17</volume>(<issue>13&#x2013;14</issue>):<fpage>1620</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/s0264-410x(98)00426-5</pub-id></mixed-citation></ref>
<ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname> <given-names>S</given-names></name> <name><surname>Finn</surname> <given-names>A</given-names></name></person-group>. <article-title>Pediatric combination vaccines</article-title>. <source>Curr Opin Pediatr</source>. (<year>1999</year>) <volume>11</volume>(<issue>1</issue>):<fpage>14</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1097/00008480-199902000-00004</pub-id><pub-id pub-id-type="pmid">10084078</pub-id></mixed-citation></ref>
<ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elenge</surname> <given-names>DM</given-names></name> <name><surname>Heo</surname> <given-names>JS</given-names></name> <name><surname>Kim</surname> <given-names>SS</given-names></name> <name><surname>Lee</surname> <given-names>JH</given-names></name> <name><surname>Xavier</surname> <given-names>S</given-names></name> <name><surname>Bahar</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants</article-title>. <source>Hum Vaccines Immunother</source>. (<year>2024</year>) <volume>20</volume>(<issue>1</issue>):<fpage>2406060</fpage>. <pub-id pub-id-type="doi">10.1080/21645515.2024.2406060</pub-id></mixed-citation></ref>
<ref id="B105"><label>105.</label><mixed-citation publication-type="other"><comment>2024 meeting: WHO Product Development for Vaccines Advisory Committee Meeting (PDVAC). (2024). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/events/detail/2024/12/09/default-calendar/2024-meeting-who-product-development-for-vaccines-advisory-committee-meeting-(pdvac)">https://www.who.int/news-room/events/detail/2024/12/09/default-calendar/2024-meeting-who-product-development-for-vaccines-advisory-committee-meeting-(pdvac)</ext-link> <comment>(Accessed November 24, 2025)</comment>.</mixed-citation></ref>
<ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>JC</given-names></name> <name><surname>Banerjee</surname> <given-names>S</given-names></name> <name><surname>Bhagi</surname> <given-names>A</given-names></name> <name><surname>Sarkar</surname> <given-names>A</given-names></name> <name><surname>Kapuria</surname> <given-names>B</given-names></name> <name><surname>Desai</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Blockchain technology for immunisation documentation in India: findings from a simulation pilot</article-title>. <source>Lancet Glob Health</source>. (<year>2021</year>) <volume>9</volume>:<fpage>S22</fpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(21)00130-3</pub-id></mixed-citation></ref>
<ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qazi</surname> <given-names>S</given-names></name> <name><surname>Usman</surname> <given-names>M</given-names></name> <name><surname>Mahmood</surname> <given-names>A</given-names></name></person-group>. <article-title>A data-driven framework for introducing predictive analytics into expanded program on immunization in Pakistan</article-title>. <source>Wien Klin Wochenschr</source>. (<year>2021</year>) <volume>133</volume>(<issue>13</issue>):<fpage>695</fpage>&#x2013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1007/s00508-020-01737-3</pub-id><pub-id pub-id-type="pmid">32945946</pub-id></mixed-citation></ref>
<ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitaka</surname> <given-names>SB</given-names></name> <name><surname>Rujumba</surname> <given-names>J</given-names></name> <name><surname>Zalwango</surname> <given-names>SK</given-names></name> <name><surname>Pfeffer</surname> <given-names>B</given-names></name> <name><surname>Kizza</surname> <given-names>L</given-names></name> <name><surname>Nattimba</surname> <given-names>JP</given-names></name><etal/></person-group> <article-title>SEARCH Study: text messages and automated phone reminders for HPV vaccination in Uganda: randomized controlled trial</article-title>. <source>JMIR MHealth UHealth</source>. (<year>2025</year>) <volume>13</volume>:<fpage>e63527</fpage>. <pub-id pub-id-type="doi">10.2196/63527</pub-id><pub-id pub-id-type="pmid">40324213</pub-id></mixed-citation></ref>
<ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazi</surname> <given-names>AM</given-names></name> <name><surname>Qazi</surname> <given-names>SA</given-names></name> <name><surname>Khawaja</surname> <given-names>S</given-names></name> <name><surname>Ahsan</surname> <given-names>N</given-names></name> <name><surname>Ahmed</surname> <given-names>RM</given-names></name> <name><surname>Sameen</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>An artificial intelligence&#x2013;based, personalized smartphone app to improve childhood immunization coverage and timelines among children in Pakistan: protocol for a randomized controlled trial</article-title>. <source>JMIR Res Protoc</source>. (<year>2020</year>) <volume>9</volume>(<issue>12</issue>):<fpage>e22996</fpage>. <pub-id pub-id-type="doi">10.2196/22996</pub-id><pub-id pub-id-type="pmid">33274726</pub-id></mixed-citation></ref>
<ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaempanah</surname> <given-names>F</given-names></name> <name><surname>Moasses Ghafari</surname> <given-names>B</given-names></name> <name><surname>Hesami</surname> <given-names>D</given-names></name> <name><surname>Hossein Zadeh</surname> <given-names>R</given-names></name> <name><surname>Noroozpoor</surname> <given-names>R</given-names></name> <name><surname>Moodi Ghalibaf</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Metaverse and its impact on medical education and health care system: A narrative review</article-title>. <source>Health Sci Rep</source>. (<year>2024</year>) <volume>7</volume>(<issue>9</issue>):<fpage>e70100</fpage>. <pub-id pub-id-type="doi">10.1002/hsr2.70100</pub-id><pub-id pub-id-type="pmid">39323461</pub-id></mixed-citation></ref>
<ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>H</given-names></name> <name><surname>Rammohan</surname> <given-names>A</given-names></name></person-group>. <article-title>Childhood immunization and age-appropriate vaccinations in Indonesia</article-title>. <source>BMC Public Health</source>. (<year>2022</year>) <volume>22</volume>(<issue>1</issue>):<fpage>2023</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-022-14408-x</pub-id><pub-id pub-id-type="pmid">36333713</pub-id></mixed-citation></ref>
<ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutambo</surname> <given-names>C</given-names></name> <name><surname>Shumba</surname> <given-names>K</given-names></name> <name><surname>Hlongwana</surname> <given-names>KW</given-names></name></person-group>. <article-title>Exploring the mechanism through which a child-friendly storybook addresses barriers to child-participation during HIV care in primary healthcare settings in KwaZulu-Natal, South Africa</article-title>. <source>BMC Public Health</source>. (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>508</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-021-10483-8</pub-id><pub-id pub-id-type="pmid">33726682</pub-id></mixed-citation></ref>
<ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goggin</surname> <given-names>K</given-names></name> <name><surname>Hurley</surname> <given-names>EA</given-names></name> <name><surname>Bradley-Ewing</surname> <given-names>A</given-names></name> <name><surname>Bickford</surname> <given-names>C</given-names></name> <name><surname>Lee</surname> <given-names>BR</given-names></name> <name><surname>Pina</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Reductions in parent interest in receiving antibiotics following a 90-second video intervention in outpatient pediatric clinics</article-title>. <source>J Pediatr</source>. (<year>2020</year>) <volume>225</volume>:<fpage>138</fpage>&#x2013;<lpage>145.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2020.06.027</pub-id><pub-id pub-id-type="pmid">32553835</pub-id></mixed-citation></ref>
<ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanschik</surname> <given-names>D</given-names></name> <name><surname>Bruno</surname> <given-names>RR</given-names></name> <name><surname>Wolff</surname> <given-names>G</given-names></name> <name><surname>Kelm</surname> <given-names>M</given-names></name> <name><surname>Jung</surname> <given-names>C</given-names></name></person-group>. <article-title>Virtual and augmented reality in intensive care medicine: a systematic review</article-title>. <source>Ann Intensive Care</source>. (<year>2023</year>) <volume>13</volume>(<issue>1</issue>):<fpage>81</fpage>. <pub-id pub-id-type="doi">10.1186/s13613-023-01176-z</pub-id><pub-id pub-id-type="pmid">37695464</pub-id></mixed-citation></ref>
<ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nino</surname> <given-names>F</given-names></name> <name><surname>Lucija</surname> <given-names>G</given-names></name> <name><surname>Leona</surname> <given-names>C</given-names></name> <name><surname>Alenka</surname> <given-names>N</given-names></name> <name><surname>Masterson</surname> <given-names>CR</given-names></name> <name><surname>Pavel</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>The effects of gamification and oral self-care on oral hygiene in children: systematic search in app stores and evaluation of apps</article-title>. <source>JMIR MHealth UHealth</source>. (<year>2020</year>) <volume>8</volume>(<issue>7</issue>):<fpage>e16365</fpage>. <pub-id pub-id-type="doi">10.2196/16365</pub-id><pub-id pub-id-type="pmid">32673235</pub-id></mixed-citation></ref>
<ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>P</given-names></name> <name><surname>Skouloudis</surname> <given-names>AN</given-names></name> <name><surname>Bell</surname> <given-names>M</given-names></name> <name><surname>Viana</surname> <given-names>M</given-names></name> <name><surname>Carotta</surname> <given-names>MC</given-names></name> <name><surname>Biskos</surname> <given-names>G</given-names></name><etal/></person-group> <article-title>Real-time sensors for indoor air monitoring and challenges ahead in deploying them to urban buildings</article-title>. <source>Sci Total Environ</source>. (<year>2016</year>) <volume>560&#x2212;561</volume>:<fpage>150</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2016.04.032</pub-id></mixed-citation></ref>
<ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castell</surname> <given-names>N</given-names></name> <name><surname>Schneider</surname> <given-names>P</given-names></name> <name><surname>Grossberndt</surname> <given-names>S</given-names></name> <name><surname>Fredriksen</surname> <given-names>MF</given-names></name> <name><surname>Sousa-Santos</surname> <given-names>G</given-names></name> <name><surname>Vogt</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Localized real-time information on outdoor air quality at kindergartens in Oslo, Norway using low-cost sensor nodes</article-title>. <source>Environ Res</source>. (<year>2018</year>) <volume>165</volume>:<fpage>410</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.envres.2017.10.019</pub-id><pub-id pub-id-type="pmid">29106951</pub-id></mixed-citation></ref>
<ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname> <given-names>CC</given-names></name> <name><surname>Kamarudin</surname> <given-names>LM</given-names></name> <name><surname>Zakaria</surname> <given-names>A</given-names></name> <name><surname>Nishizaki</surname> <given-names>H</given-names></name> <name><surname>Ramli</surname> <given-names>N</given-names></name> <name><surname>Mao</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Real-Time in-vehicle air quality monitoring system using machine learning prediction algorithm</article-title>. <source>Sensors</source>. (<year>2021</year>) <volume>21</volume>(<issue>15</issue>):<fpage>4956</fpage>. <pub-id pub-id-type="doi">10.3390/s21154956</pub-id><pub-id pub-id-type="pmid">34372192</pub-id></mixed-citation></ref>
<ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname> <given-names>R</given-names></name> <name><surname>Akbar</surname> <given-names>N</given-names></name> <name><surname>Khatoon</surname> <given-names>B</given-names></name> <name><surname>Kawish</surname> <given-names>M</given-names></name> <name><surname>Ali</surname> <given-names>MS</given-names></name> <name><surname>Shah</surname> <given-names>MR</given-names></name><etal/></person-group> <article-title>Novel plant-based metabolites as disinfectants against acanthamoeba castellanii</article-title>. <source>Antibiot Basel Switz</source>. (<year>2022</year>) <volume>11</volume>(<issue>2</issue>):<fpage>248</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics11020248</pub-id></mixed-citation></ref>
<ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>YH</given-names></name> <name><surname>Jang</surname> <given-names>YH</given-names></name> <name><surname>Kim</surname> <given-names>YS</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <name><surname>Seong</surname> <given-names>BL</given-names></name></person-group>. <article-title>Evaluation of green tea extract as a safe personal hygiene against viral infections</article-title>. <source>J Biol Eng</source>. (<year>2018</year>) <volume>12</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-017-0092-1</pub-id><pub-id pub-id-type="pmid">29339972</pub-id></mixed-citation></ref>
<ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E9;rez</surname> <given-names>SA</given-names></name> <name><surname>D&#x00ED;az</surname> <given-names>AM</given-names></name> <name><surname>L&#x00F3;pez</surname> <given-names>DM</given-names></name></person-group>. <article-title>Personalized tracking of physical activity in children using a wearable heart rate monitor</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>(<issue>16</issue>):<fpage>5895</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17165895</pub-id></mixed-citation></ref>
<ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>S</given-names></name> <name><surname>Ma</surname> <given-names>L</given-names></name> <name><surname>Ye</surname> <given-names>H</given-names></name> <name><surname>Lin</surname> <given-names>J</given-names></name> <name><surname>Cai</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Recent advances in wearable medical diagnostic sensors and new therapeutic dosage forms for fever in children</article-title>. <source>J Pharm Biomed Anal</source>. (<year>2022</year>) <volume>220</volume>:<fpage>115006</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2022.115006</pub-id><pub-id pub-id-type="pmid">36007307</pub-id></mixed-citation></ref>
<ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farner</surname> <given-names>L</given-names></name> <name><surname>K&#x00F6;nig</surname> <given-names>C</given-names></name> <name><surname>R&#x00F6;ssler</surname> <given-names>J</given-names></name> <name><surname>Schneider</surname> <given-names>C</given-names></name> <name><surname>Wyss</surname> <given-names>J</given-names></name> <name><surname>Ammann</surname> <given-names>RA</given-names></name><etal/></person-group> <article-title>Vital signs continuously monitored by two wearable devices in pediatric oncology patients, NCT04914702</article-title>. <source>Sci Data</source>. (<year>2025</year>) <volume>12</volume>(<issue>1</issue>):<fpage>807</fpage>. <pub-id pub-id-type="doi">10.1038/s41597-025-05081-x</pub-id><pub-id pub-id-type="pmid">40382374</pub-id></mixed-citation></ref>
<ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname> <given-names>S</given-names></name> <name><surname>Yang</surname> <given-names>S</given-names></name> <name><surname>Kou</surname> <given-names>SC</given-names></name></person-group>. <article-title>Accurate regional influenza epidemics tracking using internet search data</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>5238</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-41559-6</pub-id><pub-id pub-id-type="pmid">30918276</pub-id></mixed-citation></ref>
<ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname> <given-names>TK</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Guo</surname> <given-names>Y</given-names></name> <name><surname>Lau</surname> <given-names>EHY</given-names></name> <name><surname>Cowling</surname> <given-names>BJ</given-names></name> <name><surname>Ip</surname> <given-names>DKM</given-names></name></person-group>. <article-title>Monitoring school absenteeism for influenza-like illness surveillance: systematic review and meta-analysis</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2023</year>) <volume>9</volume>:<fpage>e41329</fpage>. <pub-id pub-id-type="doi">10.2196/41329</pub-id><pub-id pub-id-type="pmid">36630159</pub-id></mixed-citation></ref>
<ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>RS</given-names></name></person-group>. <article-title>Electronic health records: then, now, and in the future</article-title>. <source>Yearb Med Inform</source>. (<year>2016</year>) <volume>25</volume>(<issue>Suppl 1</issue>):<fpage>S48</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.15265/IYS-2016-s006</pub-id></mixed-citation></ref>
<ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Vermund</surname> <given-names>SH</given-names></name></person-group>. <article-title>Blockchain technology for electronic health records</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2022</year>) <volume>19</volume>(<issue>23</issue>):<fpage>15577</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph192315577</pub-id><pub-id pub-id-type="pmid">36497654</pub-id></mixed-citation></ref>
<ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCool</surname> <given-names>N</given-names></name> <name><surname>Reidy</surname> <given-names>J</given-names></name> <name><surname>Steadman</surname> <given-names>S</given-names></name> <name><surname>Nagpal</surname> <given-names>V</given-names></name></person-group>. <article-title>The buddy system: an intervention to reduce distress and compassion fatigue and promote resilience on a palliative care team during the COVID-19 pandemic</article-title>. <source>J Soc Work End&#x2013;Life Palliat Care</source>. (<year>2022</year>) <volume>18</volume>(<issue>4</issue>):<fpage>302</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1080/15524256.2022.2122650</pub-id></mixed-citation></ref>
<ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fo</surname> <given-names>WS</given-names></name> <name><surname>O&#x2019;Donnell</surname> <given-names>CR</given-names></name></person-group>. <article-title>The buddy system: relationship and contingency conditions in a community intervention program for youth with nonprofessionals as behavior change agents</article-title>. <source>J Consult Clin Psychol</source>. (<year>1974</year>) <volume>42</volume>(<issue>2</issue>):<fpage>163</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1037/h0036260</pub-id><pub-id pub-id-type="pmid">4823551</pub-id></mixed-citation></ref>
<ref id="B130"><label>130.</label><mixed-citation publication-type="other"><comment>Community-Based Public Health, Certificate. Johns Hopkins University Academic Catalogue. Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://e-catalogue.jhu.edu/public-health/certificates/community-based-public-health/">https://e-catalogue.jhu.edu/public-health/certificates/community-based-public-health/</ext-link> <comment>(Accessed June 24, 2025)</comment>.</mixed-citation></ref>
<ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Ding</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>W</given-names></name></person-group>. <article-title>Enhancing vaccination uptake through community engagement: evidence from China</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>(<issue>1</issue>):<fpage>10845</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-61583-5</pub-id><pub-id pub-id-type="pmid">38736012</pub-id></mixed-citation></ref>
<ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>YC</given-names></name> <name><surname>Williams-Bouyer</surname> <given-names>N</given-names></name> <name><surname>Ren</surname> <given-names>P</given-names></name> <name><surname>Patel</surname> <given-names>JA</given-names></name></person-group>. <article-title>Earlier and prolonged respiratory syncytial virus (RSV) seasons in young children compared to adults: implications for prevention in infants</article-title>. <source>Microbiol Spectr</source> (<year>2025</year>) <volume>13</volume>(<issue>11</issue>):<fpage>e01599-25</fpage>. <pub-id pub-id-type="doi">10.1128/spectrum.01599-25</pub-id><pub-id pub-id-type="pmid">40996227</pub-id></mixed-citation></ref>
<ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Q</given-names></name></person-group>. <article-title>Early warning signs for monitoring airborne respiratory virus transmission</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2025</year>) <volume>22</volume>(<issue>7</issue>):<fpage>1151</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph22071151</pub-id><pub-id pub-id-type="pmid">40724216</pub-id></mixed-citation></ref>
<ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>DM</given-names></name> <name><surname>Reyne</surname> <given-names>MI</given-names></name> <name><surname>Allingham</surname> <given-names>P</given-names></name> <name><surname>Levickas</surname> <given-names>A</given-names></name> <name><surname>Bell</surname> <given-names>SH</given-names></name> <name><surname>Lock</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Genomic analysis and surveillance of respiratory syncytial virus using wastewater-based epidemiology</article-title>. <source>J Infect Dis</source>. (<year>2024</year>) <volume>230</volume>(<issue>4</issue>):<fpage>e895</fpage>&#x2013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiae205</pub-id><pub-id pub-id-type="pmid">38636496</pub-id></mixed-citation></ref>
<ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name></person-group>. <article-title>SHARP: blockchain-powered WSNs for real-time student health monitoring and personalized learning</article-title>. <source>Sensors</source>. (<year>2025</year>) <volume>25</volume>(<issue>16</issue>):<fpage>4885</fpage>. <pub-id pub-id-type="doi">10.3390/s25164885</pub-id><pub-id pub-id-type="pmid">40871747</pub-id></mixed-citation></ref>
<ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname> <given-names>KKW</given-names></name> <name><surname>Yip</surname> <given-names>CCY</given-names></name> <name><surname>Lai</surname> <given-names>CYW</given-names></name> <name><surname>Wong</surname> <given-names>CKH</given-names></name> <name><surname>Ho</surname> <given-names>DTY</given-names></name> <name><surname>Pang</surname> <given-names>PKP</given-names></name><etal/></person-group> <article-title>Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study</article-title>. <source>Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis</source>. (<year>2019</year>) <volume>25</volume>(<issue>3</issue>):<fpage>372</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2018.06.009</pub-id></mixed-citation></ref>
<ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Balakuntala</surname> <given-names>MV</given-names></name> <name><surname>Qui&#x00F1;ones</surname> <given-names>JJ</given-names></name> <name><surname>Kaur</surname> <given-names>U</given-names></name> <name><surname>Moser</surname> <given-names>AE</given-names></name> <name><surname>Doosttalab</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Occupant-centric robotic air filtration and planning for classrooms for safer school reopening amid respiratory pandemics</article-title>. <source>Robot Auton Syst</source>. (<year>2022</year>) <volume>147</volume>:<fpage>103919</fpage>. <pub-id pub-id-type="doi">10.1016/j.robot.2021.103919</pub-id></mixed-citation></ref>
<ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorquera</surname> <given-names>PA</given-names></name> <name><surname>Tripp</surname> <given-names>RA</given-names></name></person-group>. <article-title>Synthetic biodegradable microparticle and nanoparticle vaccines against the respiratory syncytial virus</article-title>. <source>Vaccines (Basel)</source>. (<year>2016</year>) <volume>4</volume>(<issue>4</issue>):<fpage>45</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines4040045</pub-id><pub-id pub-id-type="pmid">27918420</pub-id></mixed-citation></ref>
<ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname> <given-names>S</given-names></name> <name><surname>Morikawa</surname> <given-names>Y</given-names></name> <name><surname>Yahagi</surname> <given-names>N</given-names></name></person-group>. <article-title>Development and validation of a temporal progression-based risk assessment tool for respiratory syncytial virus infection in infants</article-title>. <source>Pediatr Infect Dis J</source>. (<year>2025</year>) <volume>44</volume>(<issue>12</issue>):<fpage>1145</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0000000000004912</pub-id><pub-id pub-id-type="pmid">40674645</pub-id></mixed-citation></ref>
<ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschovis</surname> <given-names>PP</given-names></name> <name><surname>Sampayo</surname> <given-names>EM</given-names></name> <name><surname>Cook</surname> <given-names>A</given-names></name> <name><surname>Doros</surname> <given-names>G</given-names></name> <name><surname>Parry</surname> <given-names>BA</given-names></name> <name><surname>Lombay</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>The diagnosis of respiratory disease in children using a phone-based cough and symptom analysis algorithm: the smartphone recordings of cough sounds 2 (SMARTCOUGH-C 2) trial design</article-title>. <source>Contemp Clin Trials</source>. (<year>2021</year>) <volume>101</volume>:<fpage>106278</fpage>. <pub-id pub-id-type="doi">10.1016/j.cct.2021.106278</pub-id><pub-id pub-id-type="pmid">33444779</pub-id></mixed-citation></ref>
<ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>C</given-names></name> <name><surname>Austin</surname> <given-names>R</given-names></name> <name><surname>Wurtz</surname> <given-names>R</given-names></name> <name><surname>Delaney</surname> <given-names>CW</given-names></name> <name><surname>Rajamani</surname> <given-names>S</given-names></name></person-group>. <article-title>Applications of artificial intelligence in the control of infectious diseases in the post-COVID era: scoping review</article-title>. <source>JMIR Nurs</source>. (<year>2025</year>) <volume>8</volume>:<fpage>e84242</fpage>. <pub-id pub-id-type="doi">10.2196/84242</pub-id><pub-id pub-id-type="pmid">41248320</pub-id></mixed-citation></ref>
<ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name></person-group>. <article-title>Regulating China&#x2019;s health code system to prepare for future pandemics</article-title>. <source>Front Public Health</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1208615</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2023.1208615</pub-id><pub-id pub-id-type="pmid">37841734</pub-id></mixed-citation></ref>
<ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname> <given-names>JC</given-names></name> <name><surname>Rockl&#x00F6;v</surname> <given-names>J</given-names></name> <name><surname>Ebi</surname> <given-names>KL</given-names></name></person-group>. <article-title>Climate change and cascading risks from infectious disease</article-title>. <source>Infect Dis Ther</source>. (<year>2022</year>) <volume>11</volume>(<issue>4</issue>):<fpage>1371</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-022-00647-3</pub-id><pub-id pub-id-type="pmid">35585385</pub-id></mixed-citation></ref>
<ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>T</given-names></name> <name><surname>Song</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Zhao</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name></person-group>. <article-title>Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology</article-title>. <source>J Biosaf Biosecurity</source>. (<year>2022</year>) <volume>4</volume>(<issue>1</issue>):<fpage>59</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jobb.2022.02.002</pub-id></mixed-citation></ref>
<ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Impelluso</surname> <given-names>G</given-names></name> <name><surname>Lentzos</surname> <given-names>F</given-names></name></person-group>. <article-title>The threat of synthetic smallpox: european perspectives</article-title>. <source>Health Secur</source>. (<year>2017</year>) <volume>15</volume>(<issue>6</issue>):<fpage>582</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/hs.2017.0045</pub-id><pub-id pub-id-type="pmid">29178813</pub-id></mixed-citation></ref>
<ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>S</given-names></name></person-group>. <article-title>How genetically modified mosquitoes could eradicate malaria</article-title>. <source>Nature</source>. (<year>2023</year>) <volume>618</volume>(<issue>7967</issue>):<fpage>S29</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-023-02051-4</pub-id><pub-id pub-id-type="pmid">37380677</pub-id></mixed-citation></ref>
<ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname> <given-names>A</given-names></name> <name><surname>Galizi</surname> <given-names>R</given-names></name> <name><surname>Kyrou</surname> <given-names>K</given-names></name> <name><surname>Simoni</surname> <given-names>A</given-names></name> <name><surname>Siniscalchi</surname> <given-names>C</given-names></name> <name><surname>Katsanos</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector anopheles gambiae</article-title>. <source>Nat Biotechnol</source>. (<year>2016</year>) <volume>34</volume>(<issue>1</issue>):<fpage>78</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3439</pub-id><pub-id pub-id-type="pmid">26641531</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2399482/overview">Srivastava Vartika</ext-link>, Lerner Research Institute, Cleveland Clinic, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1095583/overview">Jonathan Hare</ext-link>, BioLife Research Limited, Kenya</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3054235/overview">Ismael Villanueva Miranda</ext-link>, University of Texas Southwestern Medical Center, United States</p></fn>
</fn-group>
</back>
</article>